TRIPLE-S MANAGEMENT CORPORATION
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT
PURSUANT TO SECTION 14(A) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
þ Preliminary Proxy Statement
o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to §240.14a-12
Triple-S Management Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ No fee required.
o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it
was determined): |
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
o |
|
Fee paid previously with preliminary materials. |
o |
|
Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and
identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by
registration statement number, or the Form or
Schedule and the date of its filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No: |
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
March 27, 2008
Dear Shareholders:
We cordially invite you to our Annual Meeting of Shareholders.
The meeting will be held on Sunday, April 27, 2008 at
9:00 a.m. at the Ponce de León Rooms A, B, and C of
the Condado Plaza Hotel, 999 Ashford Avenue in
San Juan, Puerto Rico. At the meeting, among other matters,
shareholders will be asked to elect nominees for the Board of
Directors, amend our Amended and Restated Articles of
Incorporation, and approve the Triple-S Management Corporation
2007 Incentive Plan.
Your vote is very important. Please take the time to carefully
read each of the proposals described in the attached Proxy
Statement. It is important that your shares be represented and
voted at the meeting. Whether you plan to attend or not, please
sign, date, and return the proxy card solicited by our Board of
Directors. You may vote by mail by sending the enclosed proxy
card in the postage-paid envelope enclosed for your convenience.
Also, you may vote by telephone or by internet at:
|
|
|
|
|
TELEPHONE:
|
|
INTERNET:
|
|
BY MAIL:
|
|
|
|
|
|
1-800-PROXIES
|
|
www.voteproxy.com
|
|
Use the prepaid envelope
|
(1-800-776-9437)
Follow the instructions and have your proxy card available when
you call.
|
|
Follow the on-screen instructions and have your proxy card
available when you access the web page.
|
|
|
We strongly encourage you to vote in the above mentioned manner.
Shareholders who do not register their proxies before the day of
the meeting may register them on Sunday, April 27, 2008,
from 8:00 a.m. until 9:00 a.m.
To accelerate the process of registration, we enclose a proxy
card, printed with your name and the amount of shares registered
in your name. We are sure that this will contribute to the
success of the proxy registration process.
This proxy statement and the accompanying proxy card are being
mailed to our shareholders beginning on or about March 27,
2008.
Your
Board of Directors is counting on your participation. Your vote
is important!
Sincerely,
Wilmer Rodríguez-Silva, MD
Chairman of the Board
Triple-S
Management Corporation
P.O. Box 363628
San Juan, Puerto Rico
00936-3628
NOTICE OF ANNUAL MEETING OF
SHAREHOLDERS
to be held on Sunday, April 27, 2008
To our Shareholders:
NOTICE IS HEREBY GIVEN that our Annual Meeting of Shareholders
for 2008 will be held at 9:00 a.m. on Sunday,
April 27, 2008, at the Ponce de León Rooms A, B, and C
of the Condado Plaza Hotel, 999 Ashford Avenue, San Juan,
Puerto Rico.
At the meeting, shareholders will be asked to:
(1) Elect three Group 1 directors for a
three-year term;
(2) Amend Article TENTH B of the Amended and Restated
Articles of Incorporation of the Corporation;
(3) Amend Article TENTH C of the Amended and Restated
Articles of Incorporation of the Corporation;
(4) Approve the Triple-S Management Corporation 2007
Incentive Plan; and
(5) Consider any other business properly brought before the
meeting.
Shareholders of record entitled to vote at the close of business
on March 18, 2008, shall receive notice of and shall vote
at the meeting.
You are cordially invited to attend the meeting. Whether you
plan to attend or not, please sign and return the enclosed proxy
card in order to ensure the presence of a quorum at the meeting.
A postage-paid envelope is enclosed for your convenience. For
further details please refer to the enclosed proxy card.
By order of the Board of Directors,
LUIS A. CLAVELL-RODRÍGUEZ, MD
Secretary of the Board
San Juan, Puerto Rico,
March 27, 2008.
i
CONTENTS
|
|
|
|
|
|
|
|
1
|
|
|
|
|
4
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
8
|
|
|
|
|
8
|
|
|
|
|
8
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
10
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
|
|
|
18
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
24
|
|
|
|
|
25
|
|
|
|
|
26
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
29
|
|
|
|
|
30
|
|
|
|
|
31
|
|
|
|
|
31
|
|
|
|
|
32
|
|
|
|
|
33
|
|
|
|
|
36
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
38
|
|
|
|
|
38
|
|
ii
ABOUT THE
MEETING
This proxy statement and the accompanying proxy card are being
mailed to shareholders beginning on or about March 27, 2008.
Who is
soliciting my vote?
The Board of Directors (Board) of Triple-S
Management Corporation (Corporation) is soliciting
your vote at the meeting.
What
will I be voting on?
|
|
|
|
|
The election of three Group 1 directors for a
three-year term (see page 8)
|
|
|
|
The amendment of Article TENTH B of the Amended and
Restated Articles of Incorporation of the Corporation
(Articles) (see page 31).
|
|
|
|
The amendment of Article TENTH C of the Articles (see
page 32).
|
|
|
|
The approval of the Triple-S Management Corporation 2007
Incentive Plan (Plan) (see page 33).
|
How
many votes do I have?
You will have one vote for every share of our Class A
common stock (hereinafter Class A shares) and
Class B common stock (hereinafter Class B
shares), entitled to vote, that you owned as of the close
of business on March 18, 2008, the record date for the
annual meeting. Class A shares and Class B shares are
sometimes referred to collectively as common stock.
How
many votes can be cast by all shareholders?
As of the record date there were 32,309,363 shares of common
stock issued and outstanding and entitled to vote, consisting of
16,042,809 issued and outstanding Class A shares and
16,266,554 issued and outstanding Class B shares. Each
share of common stock is entitled to one vote and all shares of
each class shall vote together as a single class on all matters
brought before the annual meeting. The shares are entitled to
vote by any proxy card that is properly executed and received
before 9:00 a.m. on the day of the annual meeting.
How
many shares must be present to hold the meeting?
A majority of the issued and outstanding shares of common stock
of the Corporation. If at the designated time quorum is not
reached, the annual meeting will be postponed for a half hour,
after which one-third (1/3) of the voting shares issued and
outstanding will constitute a quorum. We urge you to vote by
proxy even if you plan to attend the annual meeting so that we
will know as soon as possible that enough voting shares will be
present for us to hold the annual meeting.
How do
I vote?
You can vote either in person at the meeting, by telephone,
internet or mail, whether or not you attend the meeting.
|
|
|
|
|
To vote by mail, you must fill out the enclosed proxy
card, date and sign it, and return it in the enclosed
postage-paid
envelope.
|
|
|
|
To vote by telephone call toll-free 1-800-PROXIES
(1-800-776-9437)
from any touch-tone telephone and follow the instructions.
Please have your proxy card available when you make the call.
|
|
|
|
To vote by internet access www.voteproxy.com and follow
the on-screen instructions. Have your proxy card available when
you access the web page.
|
If you plan to vote via telephone or internet, you may enter
your voting instructions until noon Eastern Time the day before
the annual meeting. After such time voting instructions will not
be accepted via telephone or internet.
1
Who
can be present at the annual meeting?
Only holders of our common stock may be present at the annual
meeting. No other person, including those persons accompanying a
shareholder, will be allowed at the annual meeting.
To vote in person at the annual meeting or be present at the
meeting, holders of Class B shares must present a
Legal Proxy, which can be obtained through their broker.
Who
will bear the cost of soliciting proxies?
We will bear the entire cost of soliciting proxies for the
annual meeting, including the preparation, assembly, printing
and mailing of this proxy statement, the proxy card and any
additional solicitation materials furnished to shareholders. The
original solicitation of proxies by mail may be supplemented by
solicitation in person, telephone, facsimile, email or any other
means by our directors, officers or certain persons on behalf of
our Board. No additional compensation will be paid to those
individuals for any such services. In addition, our Board may
engage one or more solicitation agents to aid in the
solicitation of proxies. We will bear the additional costs of
such a solicitation, which, together with the costs of the
preparation, assembly, printing and mailing of this proxy
statement, the proxy card and any additional solicitation
materials furnished to shareholders, are not expected to exceed
$200,000. Currently no solicitation agents have been engaged.
Can I
change my vote?
Yes. A shareholder may revoke his or her proxy or change his or
her vote at any time before the proxy is voted at the annual
meeting. You can revoke your proxy or change your vote in one of
four ways:
1. by sending a signed notice of revocation to our
corporate secretary to revoke your proxy;
2. by sending to our corporate secretary a completed proxy
card bearing a later date than your original proxy indicating
the change in your vote;
3. by logging on to the Internet website specified on the
proxy card in the same manner you would to submit your proxy
electronically or calling the telephone number specified on the
proxy card, and in each case following the instructions to
revoke or change your vote; or
4. by attending the annual meeting and voting in person,
which will automatically cancel any proxy previously given, or
by revoking your proxy in person.
If you choose any of the first two methods, you must take the
described action no later than the 2008 annual meeting. If you
choose the third method, you have until noon Eastern Time the
day before the annual meeting to enter instructions to revoke or
change your vote. If your shares are held in street name by a
broker, bank or other financial institution, you must contact
that institution to change your vote.
How
are my votes counted?
You may either vote for or withhold authority to
vote for each nominee for our Board. You may vote for or
against or you may abstain on the other proposals.
If you withhold authority to vote with respect to any
nominee, your shares will be counted for purposes of
establishing a quorum, but will have no effect on the election
of that nominee. If you abstain from voting on the other
proposals, your shares will be counted as present for purposes
of establishing a quorum, and the abstention will have the same
effect as a vote against that proposal.
How
many votes are required to elect directors and to adopt the
other proposals?
Directors are elected (Proposal 1) by a majority of
the votes cast by the holders of our common stock at the annual
meeting.
The amendment of the Articles (Proposals 2 and 3), and the
approval of the Plan (Proposal 4) require the
affirmative vote of a majority of the issued and outstanding
shares of common stock, entitled to vote, as of the record date.
2
Could
other matters be decided at the meeting?
We do not know of any other matters that may come before the
annual meeting. However, if any new matter requiring the vote of
our shareholders is properly presented before the annual
meeting, proxies may be voted with respect thereto at the
discretion of the proxy holders.
What
happens if the meeting is postponed or adjourned?
Your proxy will still be good and may be voted at the postponed
or adjourned meeting. You will still be able to change or revoke
your proxy until it is voted.
What
should I receive?
This proxy statement, our Annual Report, the Notice of Annual
Meeting of Shareholders and the proxy card, which are being
mailed to you on or about March 27, 2008. Our Annual Report
includes our audited financial statements for the year ended
December 31, 2007, duly audited by KPMG LLP, as independent
registered public accounting firm.
* * *
3
PRINCIPAL
SHAREHOLDERS
The following table shows, as of March 11, 2008, the amount
of the Corporations Class B shares beneficially owned
(unless otherwise indicated in the footnotes) by each 5%
shareholder of the Corporation. The information is based on
reports filed with the Securities and Exchange Commission
(SEC).
CLASS B
COMMON STOCK
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
|
|
|
|
Beneficial
|
|
|
Percent of
|
|
Name and Business Address of Beneficial Owner(1)
|
|
Ownership(1)
|
|
|
Class(2)
|
|
|
Gabe Hoffman(3)
|
|
|
2,831,925
|
|
|
|
17.6
|
%
|
Accipiter Capital Management, LLC
|
|
|
|
|
|
|
|
|
Candens Capital, LLC
|
|
|
|
|
|
|
|
|
399 Park Avenue, 38th Floor
|
|
|
|
|
|
|
|
|
New York, New York 10022
|
|
|
|
|
|
|
|
|
David Einhorn(4)
|
|
|
1,250,000
|
|
|
|
7.8
|
%
|
Greenlight Capital, L.L.C.
|
|
|
|
|
|
|
|
|
Greenlight Capital, Inc.
|
|
|
|
|
|
|
|
|
DME Advisors, L.P.
|
|
|
|
|
|
|
|
|
140 East
45th Street,
24th Floor
|
|
|
|
|
|
|
|
|
New York, New York 10017
|
|
|
|
|
|
|
|
|
North Run Advisors, LLC(5)
|
|
|
1,600,000
|
|
|
|
9.94
|
%
|
North Run GP, LP
|
|
|
|
|
|
|
|
|
North Run Capital, LP
|
|
|
|
|
|
|
|
|
Todd B. Hammer
|
|
|
|
|
|
|
|
|
Thomar B. Ellis
|
|
|
|
|
|
|
|
|
One International Place
|
|
|
|
|
|
|
|
|
Suite 2401
|
|
|
|
|
|
|
|
|
Boston, MA 02110
|
|
|
|
|
|
|
|
|
SAB Capital Advisors, L.L.C.(6)
|
|
|
1,329,021
|
|
|
|
8.25
|
%
|
SAB Capital Management, L.P.
|
|
|
|
|
|
|
|
|
SAB Capital Management, L.L.C.
|
|
|
|
|
|
|
|
|
Scott. A. Bommer
|
|
|
|
|
|
|
|
|
767 Fifth Avenue, 21st Floor
|
|
|
|
|
|
|
|
|
New York, New York 10153
|
|
|
|
|
|
|
|
|
T. Rowe Price Associates, Inc.(7)
|
|
|
1,322,600
|
|
|
|
8.2
|
%
|
100 E. Pratt Street
|
|
|
|
|
|
|
|
|
Baltimore, Maryland 21202
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For purposes of this table, beneficial ownership is
determined in accordance with
Rule 13d-3
under the Securities Exchange Act of 1934, as amended. |
|
(2) |
|
Based on 16,100,000 shares of Class B shares
outstanding following our initial public offering on
December 7, 2007. |
|
(3) |
|
The information set forth above is based on information
disclosed in a Schedule 13G (the Accipiter
Filing) filed with the SEC on December 21, 2007.
According to the Accipiter Filing, Accipiter Capital Management,
LLC is the beneficial owner of 1,377,516 Class B shares or
approximately 8.6% of our outstanding Class B shares as a
result of acting as investment manager to various offshore
funds. Accipiter Capital Management, LLC shares voting and
dispositive power with respect to all our Class B shares it
beneficially owns. According to the Accipiter Filing, the
interest of one of those funds, Accipiter Life Sciences
Fund II (Offshore), LTD., amounted to 914,062 shares
or approximately 5.7% of our outstanding Class B shares.
Accipiter Life Sciences Fund II (Offshore), LTD. has sole
voting and dispositive power |
4
|
|
|
|
|
with respect to all our Class B shares it beneficially
owns. According to the Accipiter Filing, Candens Capital, LLC is
the beneficial owner of 1,454,409 Class B shares or
approximately 9.0% of our outstanding Class B shares as a
result of acting as general partner of various limited
partnerships. Candens Capital, LLC shares voting and dispositive
power with respect to all our Class B shares it
beneficially owns. According to the Accipiter Filing,
Mr. Gabe Hoffman is the beneficial owner of 2,831,925
Class B shares or approximately 17.6% of our outstanding
Class B shares as a result of acting as managing member of
each of Accipiter Capital Management, LLC and Candens Capital,
LLC. Mr. Hoffman shares voting and dispositive power with
respect to all our Class B shares he beneficially owns. |
|
(4) |
|
The information set forth above is based on information
disclosed in a Schedule 13G (the Greenlight
Filing) filed with the SEC on December 17, 2007.
According to the Greenlight Filing, Mr. David Einhorn is
the beneficial owner of 1,250,000 Class B shares or
approximately 7.8% of our outstanding Class B shares as a
result of acting as principal of various general partnerships
and an investment advisor. Mr. Einhorn shares voting and
dispositive power with respect to all our Class B shares he
beneficially owns. |
|
(5) |
|
The information set forth above is based on information
disclosed in a Schedule 13G (the North Run
Filing) filed with the SEC on December 17, 2007.
According to the North Run Filing, each of North Run Capital,
LP, North Run GP, LP, North Run Advisors, LLC, Todd B. Hammer
and Thomas B. Ellis beneficially own 1,600,000 Class B
shares or approximately 9.94% of our outstanding Class B
shares. Todd B. Hammer and Thomas B. Ellis are the principals
and sole members and limited partners, as applicable, of North
Run Adivors, LLC, North Run GP, LP and North Run Capital, LP.
North Run Advisors, LLC is the general partner for both North
Run GP, LP and North Run Capital, LP. North Run GP, LP is the
general partner to various offshore funds. Each of North Run
Capital, LP, North Run GP, LP, North Run Advisors, LLC, Todd B.
Hammer and Thomas B. Ellis have sole voting and dispositive
power with respect to all our Class B shares beneficially
owned. |
|
(6) |
|
The information set forth above is based on information
disclosed in a Schedule 13G (the SAB Filing)
filed with the SEC on February 14, 2008. According to the
SAB Filing, each of SAB Capital Advisors, L.L.C.,
SAB Capital Management, L.P., SAB Capital Management,
L.L.C., and Mr. Scott A. Bommer beneficially own 1,329,021
Class B shares or approximately 8.25% of our outstanding
Class B shares. SAB Capital Advisors, L.L.C. and
SAB Capital Management, L.P. serve as the general partner
and investment manager, respectively, of various funds.
According to the SAB Filing, the interest of one of those
funds, SAB Capital Partners, L.P., amounted to
927,164 shares or approximately 5.76% of our outstanding
Class B shares. SAB Capital Partners, L.P. shares
voting and dispositive power with respect to all our
Class B shares it beneficially owns. SAB Capital
Management, L.L.C. serves as general partner to SAB Capital
Management, L.P. and Mr. Bommer is a managing member of
both of SAB Capital Advisors, L.L.C. and SAB Capital
Management, L.L.C. Each of SAB Capital Advisors, L.L.C.,
SAB Capital Management, L.P., SAB Capital Management,
L.L.C., and Mr. Scott A. Bommer share voting and
dispositive power with respect to all our Class B shares
they beneficially own. |
|
(7) |
|
These securities are owned by various individual and
institutional investors which T. Rowe Price Associates, Inc.
(Price Associates) serves as investment adviser with
power to direct investments and/or sole power to vote the
securities. For purposes of the reporting requirements of the
Securities Exchange Act of 1934, Price Associates is deemed to
be a beneficial owner of such securities; however, Price
Associates expressly disclaims that it is, in fact, the
beneficial owner of such securities. |
5
STOCK
OWNERSHIP OF DIRECTORS AND EXECUTIVE OFFICERS
The following table shows the beneficial ownership of our common
stock by our directors, nominees and certain executive officers
as of March 18, 2008, and the number of shares beneficially
owned by all directors and executive officers as a group:
COMMON
STOCK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature of
|
|
|
|
|
|
Amount and Nature of
|
|
|
|
|
|
|
Beneficial Ownership of
|
|
|
Percent of
|
|
|
Beneficial Ownership
|
|
|
Percent of
|
|
Name and Position
|
|
Class A shares(1)
|
|
|
Ownership(2)
|
|
|
Class B shares(1)
|
|
|
Ownership(3)
|
|
|
Wilmer Rodríguez-Silva, MD,
Chairman of the BoardΔ
|
|
|
30,000
|
|
|
|
|
|
|
|
3,400
|
|
|
|
|
|
Valeriano Alicea-Cruz, MD,
Director
|
|
|
4,000
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
José Arturo Álvarez-Gallardo,
Director
|
|
|
0
|
|
|
|
|
|
|
|
6,800
|
|
|
|
|
|
Jorge L. Fuentes-Benejam,
PE¨
|
|
|
0
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Luis A. Clavell-Rodríguez, MD,
Director
|
|
|
34,000
|
|
|
|
|
|
|
|
3,400
|
|
|
|
|
|
Arturo R. Córdova-López, MD,
DirectorΔ
|
|
|
2,000
|
|
|
|
|
|
|
|
1,200
|
|
|
|
|
|
Carmen Ana Culpeper-Ramírez,
Director
|
|
|
0
|
|
|
|
|
|
|
|
1,200
|
|
|
|
|
|
Porfirio E. Díaz-Torres, MD,
Director
|
|
|
8,000
|
(4)
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Antonio F. Faría-Soto,
Director
|
|
|
0
|
|
|
|
|
|
|
|
3,334
|
|
|
|
|
|
Manuel Figueroa-Collazo, PE, PhD,
Director
|
|
|
0
|
|
|
|
|
|
|
|
6,800
|
|
|
|
|
|
José Hawayek-Alemañy, MD,
Director¨
|
|
|
79,000
|
(5)
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Vicente J. León-Irizarry, CPA,
Director
|
|
|
0
|
|
|
|
|
|
|
|
1,200
|
|
|
|
|
|
Wilfredo López-Hernández, MD,
DirectorΔ
|
|
|
4,000
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
Jaime Morgan-Stubbe, Esq.,
Director
|
|
|
0
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Roberto Muñoz-Zayas, MD,
Director
|
|
|
42,000
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Miguel A. Nazario-Franco,
Director
|
|
|
0
|
|
|
|
|
|
|
|
6,800
|
|
|
|
|
|
Juan E. Rodríguez-Díaz, Esq.,
Director
|
|
|
0
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
Jesús R. Sánchez-Colón, DMD,
Director
|
|
|
9,820
|
(6)
|
|
|
|
|
|
|
1,000
|
|
|
|
|
|
Adamina Soto-Martínez, CPA,
Director¨
|
|
|
0
|
|
|
|
|
|
|
|
1,300
|
|
|
|
|
|
Ramón M. Ruiz-Comas, CPA,
President, Chief Executive
Officer, and Director
|
|
|
0
|
|
|
|
|
|
|
|
77,586
|
|
|
|
|
|
Arturo Carrión-Crespo, CPA,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
8,759
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature of
|
|
|
|
|
|
Amount and Nature of
|
|
|
|
|
|
|
Beneficial Ownership of
|
|
|
Percent of
|
|
|
Beneficial Ownership
|
|
|
Percent of
|
|
Name and Position
|
|
Class A shares(1)
|
|
|
Ownership(2)
|
|
|
Class B shares(1)
|
|
|
Ownership(3)
|
|
|
Luis A. Marini-Mir, DMD,
Executive Officer
|
|
|
1,000
|
|
|
|
|
|
|
|
3,621
|
|
|
|
|
|
Roberto Morales-Tirado, Esq.,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
3,621
|
|
|
|
|
|
Socorro Rivas-Rodríguez, CPA,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
25,962
|
|
|
|
|
|
Juan Jose Rodríguez-Gilibertys, Esq.,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
200
|
|
|
|
|
|
Juan J. Román-Jiménez, CPA,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
25,862
|
|
|
|
|
|
Eva G. Salgado-Micheo,
Executive Officer
|
|
|
0
|
|
|
|
|
|
|
|
8,059
|
|
|
|
|
|
All our directors, nominees and executive officers as a group
(27 persons)
|
|
|
213,820
|
|
|
|
1.3
|
%
|
|
|
190,704
|
|
|
|
1.2
|
%
|
|
|
|
(1) |
|
For purposes of this table, beneficial ownership is
determined in accordance with
Rule 13d-3
under the Securities Exchange Act of 1934, as amended. |
|
(2) |
|
Based on the number of shares of the Class A shares as of
March 18, 2008. |
|
(3) |
|
Based on the number of shares of the Class B shares as of
March 18, 2008. |
|
(4) |
|
Includes 2,000 shares owned by the spouse of
Dr. Díaz-Torres. |
|
(5) |
|
Includes 51,000 shares and 3,000 shares owned by the
Dr. Hawayek-Alemañys mother in law and brother
in law, respectively. |
|
(6) |
|
Includes 2,000 shares owned by the spouse of
Dr. Sánchez-Colón. |
|
Δ |
|
Doctor Wilmer Rodríguez-Silva, doctor Arturo
Córdova-López and doctor Wilfredo
López-Hernández third and final term as members
of our Board expire on April 27, 2008, the date of the 2008
annual meeting of shareholders. |
|
¨ |
|
José Hawayek-Alemañy, MD, Adamina Soto-Martínez,
CPA, and Jorge L. Fuentes Benejam, PE are nominees for our Board. |
|
|
|
CPA Ramón M. Ruiz-Comas is the President and Chief
Executive Officer. Pursuant to our Articles and our Bylaws, the
President will be a member of our Board while acting in such
capacity. |
|
|
|
Less than one percent. |
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as
amended, requires that our directors and executive officers file
with the SEC reports of ownership and changes in ownership of
our stock and to furnish us with copies of all
Section 16(a) forms they file.
Based solely on our review of the copies of such reports we
received or written representations that no other reports were
required, we believe that, during 2007, all filing requirements
applicable to our officers and directors were satisfied.
In December 2007, each of our directors and executive officers
untimely filed a Form 4, reporting shares received under
the Plan.
7
BOARD OF
DIRECTORS
Our Articles and the Bylaws of the Corporation
(Bylaws) establish that our Board shall consist of
not less than nine (9) directors, nor more than nineteen
(19) directors, from which at least the majority must be
representatives of the community, as such term is
defined by the Blue Cross and Blue Shield Association
(BCBSA). The number of directors shall be fixed from
time to time, by resolution of the Board.
Our Board is a staggered board divided into three groups,
consisting of five (5), six (6) and seven
(7) directors, respectively. Each director serves for a
term ending on the date of the third annual meeting of
shareholders following the annual meeting at which such director
was elected or until his successor has been elected and
qualified. In the event that there is a vacancy on our Board, or
a new directorship is created, our Board shall choose a
successor by the affirmative vote of a majority of the current
directors, or by an election at an annual or special meeting
called for that purpose. A director elected to fill a vacancy
shall be elected for the unexpired term of his or her
predecessor in office or, if the vacancy is caused by an
increase in the number of directors, until the next election of
one or more directors by shareholders and in either case, may be
reelected for only two (2) additional successive terms. In
accordance with our Bylaws, the President and Chief Executive
Officer, is a member of the Board and is excluded from the three
groups of directors. In addition, our Articles and Bylaws
provide that, with the exception of the President and Chief
Executive Officer, directors may not be elected to the Board for
more than three terms or serve as such for more than nine years.
Accordingly, doctor Wilmer Rodríguez-Silva, doctor Arturo
Córdova-López and doctor Wilfredo
López-Hernández are not being nominated for election
at the annual meeting.
PROPOSAL 1: ELECTION
OF THREE GROUP 1 DIRECTORS FOR A THREE-YEAR TERM
On February 28, 2008 our Board approved a resolution
reducing its size to 17 members. The effectiveness and
implementation of this resolution is contingent on the approval
by the shareholders of Proposal 2. Due to our Boards
reduction in size, Group 1 of the directors will now
be comprised of three members instead of five members. At the
annual meeting, shareholders will only be entitled to vote for
the election of the three nominees proposed by the Board.
At the meeting, three directors assigned to Group 1
will be elected to serve until the 2011 annual meeting of
shareholders or until their respective successors are elected
and qualified. The remaining 14 directors will continue to
serve as directors, as follows: until the 2009 annual meeting of
shareholders, in the case of the six directors assigned to
Group 2, and until the 2010 annual meeting of
shareholders, in the case of the seven directors assigned to
Group 3, or in each case until their successors are
elected and qualified.
The persons named as proxies in the accompanying proxy card have
advised us that, unless otherwise instructed, they intend to
vote at the meeting the shares covered by the proxies FOR
the election of the three nominees named below, and that if
any one or more of such nominees should become unavailable for
election they intend to vote such shares FOR the election
of such substitute nominees as your board may propose. We have
no knowledge that any nominee will become unavailable for
election.
Information relating to principal occupation, business
experience and directorships during the past five years
(including positions held with us, age and the period during
which each director has served) is set forth below.
* * *
NOMINEES
FOR ELECTION
Group
1 Directors Terms Expiring in 2008
José Hawayek-Alemañy, MD (59). Since
2005, Dr. Hawayek-Alemañy has served on our Board.
Since 1976, he has been a professor at the University of Puerto
Rico, School of Medicine. From 1988 to 1998, he was director of
the Office of Graduate Medical Education at the University of
Puerto Rico, School of Medicine and, from 1998 to 2002, he was
Dean of Academic Affairs at the University of Puerto Rico,
School
8
of Medicine. He is president of the OB-GYN Section of the Puerto
Rico Medical Association. Since 2000, he has represented Puerto
Rico in the Maternal Mortality & Morbidity Committee
of the American College of OB-GYN. From 2003 to 2005, he was
Senate Member and Treasurer of the OB-GYN Section of the Medical
College of Puerto Rico. He also served as president of the
Medicare Carrier Advisory Committee in Puerto Rico. He holds a
B.S. degree in pre-medicine from the University of Puerto Rico,
Mayaguez Campus, a M.D. degree from the University of Puerto
Rico, School of Medicine, and a specialty in OB-GYN from
University Hospital.
Adamina Soto-Martínez, CPA (60). Since
2002, Ms. Soto-Martínez has served on our Board. She
is treasurer of our Board. She is currently a C.P.A. and a
partner and a founding member of the firm Kevane Grant Thornton,
LLP (formerly Kevane Soto Pasarell Grant Thornton, LLP),
certified public accountants, where she has worked since 1975.
Ms. Soto-Martínez is a member of the Puerto Rico
Society of Certified Public Accountants and the American
Institute of Certified Public Accountants. She is a graduate of
the University of Puerto Rico.
Jorge L. Fuentes-Benejam, PE
(59). Mr. Fuentes-Benejam is a nominee to
our Board. Since 1986, Mr. Fuentes-Benejam has been
Chairman of the Board, President and Chief Executive Officer of
Fuentes Concrete Pile Co. Inc. and related entities. Currently,
Mr. Fuentes-Benejam is a member of the Board of Trustees of
Interamerican University. Mr. Fuentes-Benejam is a member
of the Board of VS Real Estate Group, is the Chairman of the
Board of Trustees of the Patronato del Palacio de Santa
Catalina. Mr. Fuentes-Benejam is a licensed engineer who
holds a B.S. in Mechanical Engineering from the University of
Puerto Rico, Mayagüez Campus.
MEMBERS
OF THE BOARD OF DIRECTORS
Group
2 Directors Terms Expiring in 2009
Valeriano Alicea-Cruz, MD (62). Since 2000,
Dr. Alicea-Cruz has served on our Board. He has been an
Ophthalmologist with a private practice since 1976, and has
offices in two municipalities of Puerto Rico. He is an active
member of the Puerto Rico Medical Association, the American
Academy of Ophthalmology, the Puerto Rican Society of
Ophthalmology, the University of Puerto Rico School of Medicine
Alumni Society, and the
Pan-American
Society of Ophthalmology. He has served on the Medical Board of
the Department of Transportation and Public Works, and the board
of directors of Ojos, Inc. Dr. Alicea-Cruz holds a B.S.
degree from the University of Puerto Rico, an M.D. degree from
the University of Puerto Rico, School of Medicine, and a
Postgraduate Degree in Ophthalmology from the Puerto Rico
Medical Center and Affiliate Hospitals.
José Arturo Álvarez-Gallardo
(65). Since 2000, Mr. Álvarez-Gallardo has
served on our Board. Since 1964, Mr. Alvarez-Gallardo has
served in various positions with Mendez & Co.,
Inc., where he has served as president since 1998. He has
served on the boards of directors of Mendez & Co.,
Inc., Bamco Products Corporation, International Shipping
Agency, Menaco Corporation, and Mendez Realty Equities, Inc.
Mr. Alvarez-Gallardo holds a B.B.A. degree in Business
Administration from Iona College.
Luis A. Clavell-Rodríguez, MD (56). Since
2006, Dr. Clavell-Rodríguez has served on our Board,
of which he is currently secretary. He currently serves as the
Medical Director at the San Jorge Childrens Hospital
and as the Principal Investigator for the Childrens
Oncology Group and the Dana Farber Acute Lymphoblastic Leukemia
Consortium. He has held positions as professor of Pediatrics and
Pathology at the University of Puerto Rico School of Medicine
and is a former director of Pediatric Oncology and the training
program in Pediatric Hematology/Oncology. He is certified by the
National Board of Medical Examiners, the American Board of
Pediatrics, and the Sub-Board of Pediatric Hematology/Oncology.
He is also a member of the American Society of Hematology,
American Society of Clinical Oncology and the American Society
of Pediatric Hematology/Oncology.
Dr. Clavell-Rodríguez holds a B.S. degree from the
Catholic University of Puerto Rico and an M.D. degree from the
University of Puerto Rico, School of Medicine. He also completed
his training in pediatrics at the University of California,
School of Medicine and fellowships training from Harvard Medical
School, Childrens Hospital Medical Center in Boston, MA,
and the Sidney Farber Cancer Institute.
9
Porfirio E. Díaz-Torres, MD (65). Since
2000, he has served on our Board. Since 1988,
Dr. Díaz-Torres serves as the Director of the
Cardiology Division of the Cardiology and Nuclear Center in
San Juan, Puerto Rico. Dr. Díaz-Torres is also
President of Old Harbor Brewery of Puerto Rico, Inc. and
Di Rome Productions, Inc. He is an active member of the
American College of Cardiologists and the American Medical
Association. He is active on the medical staff of Centro
Cardiovascular de Puerto Rico y del Caribe and Auxilio Mutuo
Hospital. Dr. Díaz-Torres holds a B.B.A. degree in
Business Administration from the University of Puerto Rico and
an M.D. degree from Universidad Central del Este in the
Dominican Republic.
Vicente J. León-Irizarry, CPA (69). Since
2000, Mr. León-Irizarry has served on our Board, of
which he is currently vice chairman. He is a C.P.A. and since
January 2002 he has been a business consultant. Since February
2008, he has been a director of the Tax Free Puerto Rico Fund,
Fund II and Target Maturity Fund, the Puerto Rico AAA
Portfolio Target Maturity Fund, Portfolio Bond Fund and
Portfolio Bond Fund II, the Puerto Rico Fixed Income
Fund, II, III, IV and V, the PR GNMA &
US Government Target Maturity Fund, the Puerto Rico Mortgage
Backed & US Securities Fund, the UBS IRA Select Growth
and Income Puerto Rico Fund, the Multi-Select Securities Puerto
Rico Fund and the Puerto Rico Short Term Investment Fund. He
worked as consultant for Falcón-Sánchez &
Associates, a certified public accounting firm, from February
2000 to December 2001, and as a business consultant from January
1999 to February 2000. He is a member of the Puerto Rico Society
of Certified Public Accountants. He holds a B.B.A. degree with a
major in Accounting from the University of Puerto Rico.
Jesús R. Sánchez-Colón, DMD
(52). Since 2000,
Dr. Sánchez-Colón has served on our Board. He is
currently Assistant Secretary of our Board.
Dr. Sánchez-Colón is a dentist and has had a
private practice since 1982. He is member of the College of
Dental Surgeons of Puerto Rico, where he served as secretary and
auditor, and he is also a member of the American Dental
Association. He currently serves as chairman of the board of
directors of B. Fernández & Hermanos,
Inc. and since January 2007 is member of the board of
directors of BF Holding. He has been chairman of the
board of directors of Delta Dental Plan of Puerto Rico and vice
chairman of the board of directors of the Corporation for the
Economic Development of the City of San Juan.
Dr. Sánchez-Colón holds a B.A. degree in
Psychology from St. Louis University, a D.M.D. degree from
the University of Puerto Rico, and a Postgraduate General
Practice Residency at the Veterans Administration Hospital in
San Juan, Puerto Rico.
Group
3 Directors Terms Expiring in 2010
Carmen Ana Culpeper-Ramírez (62). Since
2004, Ms. Culpeper-Ramírez has served on our Board, of
which she is currently assistant treasurer. She is currently
Vice President of Investments for BBVA Securities in Puerto
Rico. She served as the director of the Small Business
Administration (SBA) for the Puerto Rico and U.S. Virgin
Islands District from April 2004 until April 2007. From 2000 to
March 2004, she was president and chief executive officer of C.
Culpeper & Associates, a management consulting
business, which offered organizational development, project and
financial management services. She served as a member of the
board of directors of Levitt Homes, Inc., Centennial
Communications, Inc., Santander BanCorp, Intech de Puerto Rico
and as chairwoman of the board of the San Juan Human
Capital Development Board. From 1997 to 1999,
Ms. Culpeper-Ramírez worked for two years as President
of the Puerto Rico Telephone Company, the tenth largest
telephone company in the United States, and was responsible for
its sale to GTE/Verizon. From 1999 to 2000, she also served as
president of the Puerto Rico Chamber of Commerce. She holds a
B.B.A. in Finance from the University of Puerto Rico and an
M.B.A. from the University of Pennsylvania, Wharton School of
Business (International Business).
Antonio F. Faría-Soto
(59). Mr. Faría-Soto has served on our
Board since May 2007. From 2005 to 2006,
Mr. Faría-Soto was Chairman of the Board of Directors
and CEO of Doral Bank and President of Doral Money, a subsidiary
of Doral Bank. From 2003 to 2004, Mr. Faría-Soto was
President and CEO of the Government Development Bank of Puerto
Rico, and he served as ex-officio member and Chairman of the
Boards of AFICA (infrastructure development financing vehicle
for profit and non-profit organizations), the Economic
Development Bank of Puerto Rico, the Tourism Development Fund,
and the Childrens Trust Fund. He also served as a
member of the boards of the Public Buildings Authority,
Government Employees Retirement System Administration,
Puerto Rico Telephone Authority Holdings Corp., Puerto Rico
Industrial
10
Development Corp, Teachers Retirement System, Ultracom,
and Convention Center District Administration. Also, he has
served as a member of the Governors Economic Development
Council for the Government of Puerto Rico, and as member
ex-officio of FIDA and Promo Expo. From 2002 to 2003, he served
as President of the Economic Development Bank of Puerto Rico and
from 2001 to 2002 he was Commissioner of the Office of Financial
Institutions. Mr. Faría-Soto holds a B.B.A. from the
Catholic University of Puerto Rico and an M.B.A. in Finance from
the Inter American University of Puerto Rico.
Manuel Figueroa-Collazo, PE, PhD (56). Since
2004, Dr. Figueroa-Collazo has served on our Board. Since
1999, Dr. Figueroa-Collazo is President of VERNET, Inc., an
educational software development Company located in Caguas,
Puerto Rico. Dr. Figueroa-Collazo is also a member of the
Board of Directors of INTECO, Puerto Rico Products Association,
EPSCOR, and Vivero de Tecnología y Ciencia de Puerto
Rico. He has 12 years of experience in senior
management positions and over twenty years of exposure at all
management levels within the communications and systems
industries. He was general manager for Lucent Technologies,
Mexico and a Department Head at AT&T Bell Laboratories.
Dr. Figueroa-Collazo holds B.S., M.S., and Ph.D. degrees in
Electrical Engineering from the Florida Institute of Technology,
and he attended advanced management programs in INSEAD
Fontainebleau, France, and University of Pennsylvania, Wharton
School of Business.
Jaime Morgan-Stubbe, Esq.
(49). Mr. Morgan-Stubbe has served on our
Board since May 2007. Since 2000 he is an active member of the
Board of Directors of the Puerto Rico Homebuilders Association
and member of the Board of Trustees of the Palmas del Mar
Academy. From 2002 to 2004 he served as a member of the Board of
Trustees of the Baldwin School of Puerto Rico. Since 2000 he has
served as President of Palmas del Mar Properties, Inc., a land
and real estate development company and owner of the largest
master planned residential-resort community in Humacao, Puerto
Rico. Prior to becoming a real estate developer, Mr. Morgan
was a business, corporate, real estate and tax attorney. He
worked for the law firm of Goldman Antonetti &
Córdova, P.S.C. He was director of the Economic Development
Administration (FOMENTO), President of the Puerto Rico
Industrial Development Company (PRIDCO), and Executive Director
of the Puerto Rico Maritime Shipping Authority (Navieras de
Puerto Rico), during his tenure in Government from 1993 to 1999.
He graduated from Tulane University in New Orleans in 1980 and
continued graduate studies in law at the University of Puerto
Rico.
Roberto Muñoz-Zayas, MD
(78). Dr. Muñoz-Zayas has served on our
Board since May 2007. He was President of the Board of Directors
of the Regional Bank of Bayamón and the Bayamón
Mortgage Loan Corp. He also served as a member of the Board of
Directors of the Hospital Matilde Brenes, Inc.
Dr. Muñoz-Zayas was President of the Athletics
Federation of Puerto Rico, and he was President of the Colonia
Hispanoamericana de Puerto Rico, the Club Exchange in
Bayamón, and the Federation of Sport Medicine of Puerto
Rico. From 1974 to 2004, Dr. Muñoz-Zayas was Medical
Director of the Olympic Committee of Puerto Rico and the
Caribbean Series of Puerto Rico. He holds a B.A. degree in
Science from the University of Puerto Rico, a Ph.D. degree in
Medicine from the University of Santiago de Compostela, and a
Post-Graduate Degree from the Jacobi Municipal Hospital in New
York.
Miguel A. Nazario-Franco (60). Since 2004,
Mr. Nazario-Franco has served on our Board.
Mr. Nazario-Franco is an active member of the boards of
directors of FRG (formerly Ferré Investment Fund) and
Empresas Santana. He is also a member of the Advisory
Board of Cortez Industrial Organization. From 1994 to 2002,
Mr. Nazario-Franco worked for Puerto Rican Cement Co., Inc.
where he held various positions, including those of president,
chief executive officer, and president of the board of
directors. From 1995 to 2005 he served as a member of the board
of directors of El Día, Inc. From January 1999 to August
2000, he was president of the Puerto Rico Manufacturers
Association. From 2002 to 2004, he served as a member of the
Advisory Boards of the Puerto Rico Department of Education and
Consejo Asesor de la Industria de la Construcción until
December 2004. He also served on the boards of directors of the
Puerto Rico Aqueduct and Sewer Authority and Compañía
para el Desarrollo Integral de la Peninsula de Cantera until
December 2005 and on the board of directors of Puerto Rico
Electric Power Authority until January 2006.
Mr. Nazario-Franco holds a B.B.A. degree in Accounting from
the University of Puerto Rico.
Juan E. Rodríguez-Díaz, Esq.
(66). Since December 2004,
Mr. Rodríguez-Díaz has served on our Board.
Mr. Rodríguez-Díaz is a commercial, corporate and
tax attorney admitted to the practice of law in Puerto Rico and
New York who currently works as senior and managing partner of
Totti & Rodríguez Díaz. He has worked
11
in various prestigious law firms including Baker &
McKenzie, McConnell Valdés, and Sweeting, Pons,
González & Rodríguez.
Mr. Rodríguez-Díaz also served as Undersecretary
of the Department of Treasury of Puerto Rico from
1971-1973.
He serves as a member of the boards of directors of
Industrias Vassallo, Inc., Vassallo Research and
Development, Inc., Ochoa Industrial Sales Corp., Triangle Cargo
Services, Inc., and Luis Ayala Colón Sucrs., Inc.
Mr. Rodríguez-Díaz holds a B.A. degree from Yale
University, a J.D. degree from Harvard University and a Masters
of Laws (L.L.M. in taxation) from New York University, School of
Law.
MEETINGS
OF THE BOARD OF DIRECTORS AND COMMITTEES
Our Board holds scheduled meetings at least quarterly. Special
board meetings are held when convened by the Chairman, or by at
least five directors. Our Board met 20 times during 2007, and
all directors attended at least 75% of the meetings scheduled by
the Board and the committees of which they were members.
While we encourage directors to attend our annual meeting of
shareholders, we have not adopted a formal policy requiring
director attendance at the annual meeting of shareholders. All
of our directors attended the last annual meeting of
shareholders.
BOARD OF
DIRECTORS INDEPENDENCE
Our Board has determined that Mr. Álvarez-Gallardo,
Ms. Culpeper-Ramírez, Mr. Figueroa-Collazo,
Mr. León-Irizarry, Mr. Nazario-Franco,
Mr. Rodríguez-Díaz, Ms. Soto-Martínez,
Mr. Faría-Soto, Mr. Morgan-Stubbe and
Dr. Muñoz-Zayas have no material relationship with the
Corporation. Also, Mr. Jorge L.
Fuentes-Benejam
is a nominee for the Board and has no material relationship with
the Corporation. Our Board has adopted the New York Stock
Exchange (NYSE) director independence standards as
guidelines for corporate governance policy. The previously
mentioned directors are independent under these director
independence standards as determined and approved by the Board.
A copy of the Independence Standards adopted by the Board is
attached to this Proxy Statement as Exhibit A.
* * *
SHAREHOLDER
COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Any shareholder who desires to contact our Board or any of its
members individually may do so by writing to: Triple-S
Management Corporation, Board of Directors,
P.O. Box 363628, San Juan, P.R.
00936-3628.
The Board will give appropriate attention to written
communications that are submitted by the shareholders and will
respond if and as appropriate. Absent unusual circumstances or
as contemplated by committee charters and subject to any
required assistance or advice from legal counsel, the Chairman
of the Board is responsible for monitoring communications from
shareholders and for providing copies or summaries of such
communications to the other directors as he considers
appropriate. The Chairman will forward communications to all
directors if they relate to important substantive matters or
include important suggestions or comments that merit a
directors attention. In general, communications related to
corporate governance and long-term corporate strategy are more
likely to be forwarded than communications related to ordinary
business affairs, personal grievances, and matters as to which
we tend to receive repetitive or duplicative communications.
Alternatively, a shareholder may confidentially contact our
Audit Committee by calling our EthicsPoint services at the
toll-free number 1-866-384-4277 or electronically through
www.ethicspoint.com. Communications will be received by
the Audit Committee, and communications that are not related to
accounting or auditing matters, may be discretionally forwarded
by the Audit Committee or any of its members to other committees
of the Board or management for review. Communications received
by EthicsPoint are completely confidential and allow for
shareholders and employees to report any violations or
irregularities that could affect the Corporation.
* * *
12
CODE OF
BUSINESS CONDUCT AND ETHICS
The Board has established a code of business conduct and ethics
that applies to our employees, agents, independent contractors,
consultants, officers and directors. Any waiver of the code of
business conduct and ethics may be made only by our Board and
will be promptly disclosed as required by law or stock exchange
regulations. Our Board has not granted any waivers to the code
of business conduct and ethics. The complete text of the Code of
Business Conduct and Ethics is available at the
Corporations website at www.triplesmanagement.com.
* * *
STANDING
COMMITTEES
The Bylaws provide that our Board may, by resolution passed by a
majority of the entire board, designate one or more committees.
The Corporation currently has the following standing committees:
corporate governance, nominations, compensation and audit. All
members of the standing committees serve for a one year term. In
addition to these standing committees, we have a number of ad
hoc committees. According to BCBSA requirements, our officers
and employees, including those of our subsidiaries, cannot be
members of the Compensation, Nominations or Audit Committees.
A brief description of each of the Nominations Committee,
Compensation Committee and the Audit Committee is set forth
below:
Nominations
Committee
The duties of the nominations committee are to (i) identify
and recommend individuals who are best suited to become members
of our Board, who will be presented as candidates endorsed by
the Board at the annual meeting of shareholders,
(ii) recommend to our Board the best qualified candidates
to fill vacancies, (iii) evaluate the performance of the
directors pursuant to criteria and objectives established by the
Board from time to time; (iv) establish and periodically
review the qualifications of the candidates to be endorsed by
the Board and (v) recommend to the Board the best qualified
candidates to occupy the position of our president. The
Nominations Committee Charter is available at the
Corporations web site: www.triplesmanagement.com.
Also, the committee reviews and recommends a board composition
that meets the independence criteria set forth by the NYSE, the
BCBSA and good governance practices. It recommends the
nomination of directors to terms of office which meet the BCBSA
guidelines established for a staggered term board and reviews
board members group evaluations. Based on these evaluations, the
committee may either recommend re-nominations or replacements
when their terms expire, or if the members term has not
elapsed recommend corrective actions to address performance
weaknesses. If the deficiencies are of a significant nature, the
committee may recommend the replacement of such director.
The committee met 5 times during the fiscal year ended on
December 31, 2007. As of March 27, 2008, the members
of the committee are: Mr. Miguel Nazario-Franco, Chair of
the committee, Mr. Álvarez-Gallardo,
Mr. Morgan-Stubbe, Mr. Figueroa-Collazo,
Ms. Culpeper-Ramírez, Dr. Muñoz-Zayas and
Mr. Rodríguez-Díaz. The Board has determined all
members of the nominations committee are independent within the
meaning of the NYSE rules.
The nominations process followed by the committee is as follows:
(1) Shareholders may nominate candidates to the Board.
Candidates recommended by shareholders will receive the same
consideration as candidates recommended otherwise. Information
regarding candidates nominated by a shareholder must be
addressed to the attention of the Secretary of the Board.
(2) A shareholder may present a nominee at the annual
meeting if he or she is a holder of record as of the applicable
record date and such shareholder has delivered written notice of
such proposal containing the information specified in our Bylaws
not later than 120 days nor earlier than 150 days
prior to the first anniversary of the preceding years
annual meeting.
13
(3) The Nominations Committees duties are to ensure
that the Board has the plans, procedures, and resources needed
to identify, recruit, and retain directors. The Nominations
Committee will identify the individuals who, in their judgment,
are best qualified to serve on the Board and present its
recommendations to the Board for endorsement at the annual
meeting. This committee will also make recommendations to fill
any vacancies in the Board that might arise from time to time.
(4) Individuals interested in serving as directors must
meet all legal and statutory requirements. These minimum
requirements are contained in
Article 6-2
of our Bylaws. They include the following: (a) not having
filed for bankruptcy, nor granted a fraudulent general
assignment for the benefit of creditors, (b) not have been
convicted of a felony or grave misdemeanor which involves moral
depravation or turpitude, and (c) comply with any
applicable requirements under BCBSA rules.
(5) The Nominations Committee develops qualifying criteria
and is responsible for identifying, interviewing, and
recommending to the Board those potential candidates that, in
their judgment, are best qualified. Throughout this process, the
committee may verify that the selected individuals possess the
following specific qualities or skills: (a) experience or
relevant knowledge, (b) time availability and commitment,
(c) good reputation, (d) analytical thinking,
(e) ability to work as a team, (f) independent
judgment, and (g) ability to verbalize and present ideas in
a rational and eloquent fashion. In addition, the Nominations
Committee may include other requirements that it may deem
necessary to strengthen the Corporation and fulfill its needs as
vacancies occur. This practice is aimed at complying with good
corporate governance practices.
(6) The Nominations Committee has the authority to hire and
terminate the services of any professional third-party search
firm to identify potential candidates for the position of
director. During 2007, the Committee hired the services of a
third party search firm to evaluate and identify possible
nominees for the Board.
(7) The committee identified and recommended the
nominations of Dr. José Hawayek-Alemañy and
Ms. Adamina Soto-Martínez, each of whom is currently a
member of our Board.
(8) The committee also identified and recommended one
nominee who is not currently serving as director. Mr. Jorge
L. Fuentes Benejam, PE is being nominated for election for the
first time.
Compensation
Committee
The duties of the compensation committee are to
(i) develop, recommend and review the compensation policies
for our executive officers, (ii) recommend to the Board the
compensation of our executive officers and (iii) recommend
to the Board those changes to the compensation levels of our
directors that it deems necessary. The Compensations Committee
Charter is available at the Corporations web site:
www.triplesmanagement.com.
The committee met 12 times during the fiscal year ended
December 31, 2007. As of March 27, 2008, the members
of the committee are: Ms. Soto-Martínez, Chair of the
committee, Ms. Culpeper-Ramírez,
Mr. León-Irizarry, Mr. Morgan-Stubbe,
Mr. Figueroa-Collazo and Mr. Nazario-Franco.
The Board has determined that all members of the compensation
committee are independent within the meaning of NYSE rules.
For a complete discussion of the processes and procedures for
the consideration and determination of executive and director
compensation, please see the Compensation and Discussion
Analysis in this Proxy Statement.
COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
None of the members of the Compensation Committee is or has been
one of our officers or employees. None of our executive officers
served on any board of directors Compensation Committee of
any other company for which any of our directors served as an
executive officer at any time during 2007. Other than disclosed
in Other Relationships, Transactions and Events in
this proxy statement, none of the members of
14
the Compensation Committee had any relationship with us
requiring disclosure under Item 404 of the SEC
Regulation S-K.
Audit
Committee
The Audit Committee reviews the following matters: (1)
adequacy of internal controls and compliance with applicable
laws and regulations, (2) activities/reports of the
Internal Audit Office, (3) results from audits made by
regulators, (4) our consolidated financial statements, and
(5) the annual audit report prepared by the independent
registered public accounting firm. In addition, the Audit
Committee appoints the independent registered public accounting
firm to serve as our external auditors and the Vice-President of
Internal Audit, when such position becomes vacant. The Audit
Committee Charter is available at the Corporations web
site: www.triplesmanagement.com.
The committee met ten times during the fiscal year ended
December 31, 2007. As of March 27, 2008, the members
of the committee are: Mr. Vicente J. León-Irizarry
(Chair), Ms. Carmen Ana Culpeper-Ramírez,
Mr. Antonio F. Faría-Soto, Mr. Jaime
Morgan-Stubbe, Mr. Miguel Nazario-Franco and
Ms. Adamina Soto-Martínez. The Board has determined
that all members of the audit committee are independent within
the meaning of NYSE rules.
AUDIT
COMMITTEE REPORT
The Audit Committee Charter (Charter) establishes
that the Audit Committee (Committee) shall consist
of three or more members of the Board. The Board has determined
that each member of the Committee is independent. In making this
determination, the Board follows the audit committee
independence standards set forth in the NYSEs director
independence rules. Currently, the Committee is comprised of six
directors all of whom are independent under such standards. The
Committee held ten meetings during the year ended
December 31, 2007.
Form 10-K
and
Form 10-Q
filings were discussed in four of such meetings.
The role of the Committee is to assist the Board in its
oversight of our financial reporting process, as well as our
internal and external audit processes, independent registered
public accounting firms qualifications and performance of
the internal audit function. The Committee also is responsible
for the appointment, compensation, retention and oversight of
the independent registered public accounting firm and the
establishment of procedures for handling complaints. The
Committee operates pursuant to the Charter that was adopted by
the Board and ratified on January 31, 2008.
The Charter states that: (1) the Chair of the Audit
Committee shall be appointed by the members of the Committee and
(2) the Committee shall appoint the Vice-President of the
Internal Audit Office when such position is vacant. The
Committee has the resources and authority to discharge its
responsibilities, including the authority to engage independent
registered public accounting firm for special audits, reviews,
and other procedures and to retain special counsel and other
experts, consultants, or advisors. The Committee appoints or
terminates the engagement of the independent registered public
accounting firm and reviews the proposed audit scope and
approach, including coordination of the audit effort with the
Internal Audit Office.
In the performance of its oversight function, the Committee has
considered and discussed our audited consolidated financial
statements for the fiscal year ended December 31, 2007 with
management and KPMG LLP, our independent registered public
accounting firm.
The Committee has also discussed with the independent registered
public accounting firm the matters required to be discussed by
Statement on Auditing Standards No. 61, as amended,
Communication with Audit Committees. In addition,
the Committee has received the written disclosures and the
letter from KPMG LLP required by Independence Standards Board
Standard No. 1 (Independence Discussion with Audit
Committees), as currently modified or supplemented. The
Committee has also considered whether the provision of non-audit
services by the independent registered public accounting firm to
the Corporation is compatible with maintaining the
auditors independence, and has discussed with the
independent auditors the auditors independence from us and
our management.
15
As set forth in the Charter, management is responsible for:
(1) the preparation, presentation, and integrity of our
consolidated financial statements, and (2) maintaining
appropriate accounting and financial reporting principles,
policies, and internal controls and procedures that comply with
accounting standards and applicable laws and regulations. The
independent registered public accounting firm, KPMG LLP, is
responsible for auditing our consolidated financial statements
and expressing an opinion as to their conformity with
U.S. generally accepted accounting principles.
The members of the Committee are not employees of the
Corporation or any of its subsidiaries. While some of them may
be accountants or auditors by profession, the Committee relies
on, and makes no independent verification of, the financial or
other information presented to it or representations made by
management or the independent registered public accounting firm.
Accordingly, the Committees oversight does not provide an
independent basis to determine that management has maintained
appropriate accounting and financial reporting principles and
policies, or internal controls and procedures, designed to
achieve compliance with accounting standards, and applicable
laws and regulations.
Based on the Committees consideration of the audited
consolidated financial statements and the discussions referred
to above with management and the independent registered public
accounting firm, and subject to the limitations on the role and
responsibilities of the Committee set forth in the Charter and
those discussed above, the Committee recommended and the Board
approved that our audited consolidated financial statements be
included in our Annual Report on
Form 10-K
for the year ended December 31, 2007 for filing with the
SEC.
No portion of this Audit Committee Report shall be deemed to
be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended, through any general statement
incorporating by reference in its entirety the Proxy Statement
in which this report appears, except to the extent that the
Corporation specifically incorporates this report or a portion
of it by reference. In addition, this report shall not be deemed
to be filed under either the Securities Act of 1933, as amended,
or the Securities Exchange Act of 1934, as amended.
Submitted by:
Vicente J. León-Irizarry, CPA, Chair of the Audit
Committee
Carmen Ana Culpeper-Ramírez
Antonio F. Faría-Soto
Jaime Morgan-Stubbe, Esq.
Miguel A. Nazario-Franco
Adamina Soto-Martínez, CPA
Dated: March 11, 2008
AUDIT
COMMITTEE FINANCIAL EXPERTS
The Board has determined that Mr. León-Irizarry and
Ms. Soto-Martínez are the audit committee financial
experts as defined by Item 401(h) of
Regulation S-K
under the Securities Exchange Act of 1934, as amended, and are
independent within the meaning of the NYSE director independence
standards. For a brief listing of the relevant experience of the
members of the Audit Committee, please see Board of
Directors and Standing Committees above.
* * *
EXECUTIVE
OFFICERS
The following information sets forth the names of our executive
officers, including their age, education and business experience
during the past five years and the period during which each such
person has served as one of our executive officers.
16
Ramón M. Ruiz-Comas, CPA (51). Since May
2002, Mr. Ruiz-Comas has served as our president and chief
executive officer. Mr. Ruiz has also served on our Board
since May 2002. Mr. Ruiz-Comas served as our executive vice
president from November 2001 to April 2002 and as our senior
vice president and chief financial officer from February 1999 to
October 2001. From 1995 to 1999, Mr. Ruiz-Comas served as
our managed care subsidiarys senior vice president of
finance and from 1990 to 1995 he was vice president of finance.
Prior to joining us, Mr. Ruiz-Comas worked at KPMG LLP from
1978 to 1990. He is a Certified Public Accountant (CPA) and a
member of the Puerto Rico Society of Certified Public
Accountants, as well as the American Institute of Certified
Public Accountants. He holds a B.B.A. degree with a major in
Accounting from the University of Puerto Rico and a Juris
Doctor (J.D.) degree from the University of Puerto Rico,
School of Law. In 2002, he attended the Advance Management
Program at the University of Pennsylvanias Wharton School
of Business.
Socorro Rivas-Rodríguez, CPA
(60). Ms. Rivas-Rodríguez has served as
president and chief executive officer of our managed care
business since May 2002. Prior to her appointment as president
and chief executive officer, Ms. Rivas-Rodríguez
served in various positions at our managed care business,
including general manager from 1999 to 2002, executive vice
president from 1990 to 2002, and director of internal audit from
1982 to 1990. She has been a Certified Public Accountant since
1987 and a member of the Puerto Rico Society of Certified Public
Accountants. Ms. Rivas-Rodríguez has a B.A. degree
with concentrations in mathematics and accounting from the
University of Puerto Rico.
Eva G. Salgado-Micheo (50). Ms. Salgado
has served as president of our property and casualty insurance
business since July 2003. Prior to this appointment,
Ms. Salgado served in various positions in our property and
casualty insurance business, including senior vice president of
the underwriting department from 2002 to 2003, vice-president of
the underwriting department from 1997 to 2002 and vice-president
of marketing. Prior to joining our property and casualty
insurance business, Ms. Salgado worked at Integrand
Assurance Company as senior vice-president of the underwriting
department from 1992 to 1996. Ms. Salgado holds a B.A.
degree with a concentration in Finance from the University of
Puerto Rico. She also studied underwriting at the Insurance
Institute of America.
Arturo Carrión-Crespo, CPA
(50). Mr. Carrión has served as
president of our life insurance subsidiary, Triple-S Vida, Inc.
(formerly Great American Life Assurance Company (GA
Life)), since 1998. Prior to this appointment,
Mr. Carrión served as vice president of finance of GA
Life from 1987 to 1998. Prior to joining GA Life,
Mr. Carrión worked at KPMG LLP from 1978 to 1987. He
is a Certified Public Accountant and a member of the Puerto Rico
Society of Certified Public Accountants. Mr. Carrión
holds a B.B.A. degree with a major in Accounting from the
University of Puerto Rico.
Luis A. Marini-Mir (59). Dr. Marini has
been president of our Commonwealth of Puerto Rico Health Reform
business since October 1999. Prior to his appointment,
Dr. Marini served as dental director of our managed care
business from February 1998 to October 1999. From April 1975 to
December 2000, Dr. Marini had a pediatric dentistry private
practice. Dr. Marini is a former dean of the University of
Puerto Rico, School of Dentistry. Dr. Marini received a
degree from the University of Puerto Rico (Mayaguez Campus) with
a concentration in pre-medicine and obtained a D.M.D. degree
from the University of Puerto Rico, School of Dentistry. He also
obtained a Certificate in Pediatric Dentistry from the
University of Puerto Rico, School of Dentistry.
Roberto O. Morales-Tirado, Esq.
(64). Mr. Morales was appointed president of
our insurance agency, Signature Insurance Agency, in February
2006. Prior to being appointed to this position,
Mr. Morales served as president and chief executive officer
of our life insurance business from 2000 through February 2006.
From 1998 to 2000, Mr. Morales served as a consultant for
us. From 1993 to 1998, Mr. Morales served as president and
chief executive officer of AIG Life Insurance Company of Puerto
Rico. Mr. Morales received a B.A. degree from the
University of Puerto Rico and a J.D. degree from the
Interamerican University of Puerto Rico, School of Law.
Juan J. Román-Jiménez, CPA
(42). Mr. Román-Jiménez has served
as our vice president of finance and chief financial officer
since 2002. Prior to his appointment as chief financial officer,
Mr. Román-Jiménez served as executive
vice-president of our Commonwealth of Puerto Rico Health Reform
business (Triple-C,
17
Inc.) from 1999 to 2002 and vice-president of finance from 1996
to 1999. Prior to joining us, Mr. Román-Jiménez
worked at KPMG LLP from 1987 to 1995. He has been a Certified
Public Accountant and a member of the Puerto Rico Society of
Certified Public Accountants as well as the American Institute
of Certified Public Accountants since 1989. He earned a B.A.
degree in Business Administration with a concentration in
Accounting from the University of Puerto Rico, Rio Piedras.
Juan J. Rodríguez-Gilibertys, CPA
(44). Mr. Rodríguez-Gilibertys has
served as Vice-President of the Audit Department of the
Corporation since December 2004. Prior to his appointment at the
Corporation, Mr. Rodríguez-Gilibertys served as
Undersecretary of the Puerto Rico Treasury Department from
January 2001 to November 2004.
Mr. Rodríguez-Gilibertys served as Director of Finance
for the Municipality of San Juan from 1997 to 2001.
Mr. Rodríguez-Gilibertys received a degree of Bachelor
in Business Administration (B.B.A.) from the University of
Puerto Rico with a concentration in Accounting. He also received
a Juris Doctor degree from the Interamerican University
School of Law. He is a Certified Public Accountant, a Certified
Internal Auditor, a Certified Information System Auditor and a
member of the Puerto Rico Society of Certified Public
Accountants.
* * *
COMPENSATION
DISCUSSION AND ANALYSIS
The Boards Compensation Committee oversees the design and
administration of the Corporations executive and director
compensation programs. The Compensation Committee works to
ensure that the total compensation paid to the executive
officers and outside directors is fair, reasonable and
competitive with its peer group.
The individuals who served as our chief executive officer and
chief financial officer during fiscal 2007, as well as the other
individuals included in the Summary Compensation Table, are
referred to as the Named Executive Officers.
The Compensation Committee is comprised of only independent
directors and is responsible for the administration of the
Corporations executive compensation program. Prior to May
2007, the Compensation Committee was comprised of a majority of
independent directors (four out of five). The Compensation
Committee met twelve times during 2007.
The Compensation Committee has the sole authority to engage the
services of outside consultants to assist them. The Compensation
Committee retained Frederic W. Cook & Co., Inc.
(Cook) as its compensation consultant during 2007 to
advise the Compensation Committee in all matters related to the
executives and directors compensation.
Our executive compensation program is designed to support the
attainment of our vision, business strategy, and operating
imperatives. Specifically, we believe that the most effective
executive compensation program is one that is designed to reward
the achievement of specific annual and long-term goals which
align the executives interests with those of the
shareholders, and ultimately improve shareholder value.
To this end, our compensation program is designed to accomplish
the following objectives:
|
|
|
|
|
Reinforce business values through the alignment of our efforts
to deliver superior results for customers and shareholders,
belief in good governance, socially responsible business
practices, and high ethical standards.
|
|
|
|
Reinforce a high performance culture with clear emphasis on
accountability and variable pay. The variable pay program is
intended to drive a high performance culture that emphasizes
both near and longer-term results.
|
|
|
|
Deliver compensation that is reasonable and competitive so that
we can attract and retain talented leaders and motivate those
leaders to achieve superior results. At the same time, we
believe that compensation should be set responsibly to ensure a
reasonable rate of return on our human capital expenditures.
|
18
|
|
|
|
|
Require levels of share ownership that increase with role scope.
Executives will be required to own and hold a number of shares
while in executive or policymaking roles to align their economic
interests with other shareholders.
|
Determining
Executive Compensation
We compare the compensation of the Named Executive Officers to
that of companies with which we compete for talent, capital, and
for customers. Those companies include private or publicly-held
companies, stand-alone businesses or divisions of larger
corporations. Our size
and/or
organizational complexity are considered when selecting
comparable companies in Puerto Rico and the United States and
data analysis methods. Within our general competitive framework,
specific comparisons may vary by type of role.
Cook provided the Compensation Committee with relevant market
data and alternatives to consider when making compensation
decisions. Using data prepared by Cook, the Compensation
Committee compared each element of total compensation to a
defined list of direct industry competitors (Insurance and
Managed Care Peer Group).
The Insurance and Managed Care Peer Group consists of companies
against which the Compensation Committee believes we will
compete for talent, capital, and customers or are comparable to
us. The companies comprising the Insurance and Managed Care Peer
Group are:
|
|
|
|
|
AMERIGROUP Corporation
21st Century Insurance Group
|
|
Erie Indemnity Company
HCC Insurance Holdings, Inc.
|
|
Sierra Health Services, Inc.
State Auto Financial Corporation
|
Alleghany Corporation
|
|
HealthSpring, Inc.
|
|
WellCare Health Plans, Inc.
|
Aspen Insurance Holdings Ltd
|
|
Infinity Property & Casualty Corporation
|
|
Zenith National Insurance Corporation
|
Centene Corporation
|
|
Magellan Health Services
|
|
|
Delphi Financial Group, Inc.
|
|
Molina Healthcare, Inc.
|
|
|
For comparison purposes, our annual revenues are at the median
of the Insurance and Managed Care Peer Group. Total compensation
is targeted at the median (50th percentile) of the
Insurance and Managed Care Peer Group for all components of pay,
including: base salary, short and long-term variable pay
opportunities, benefits and perquisites.
Based on our compensation philosophy, a significant percentage
of total compensation is delivered in the form of incentive
compensation. There is no pre-established policy or target for
the allocation between either cash and non-cash or short-term
and long-term incentive compensation. Rather, the Compensation
Committee reviews competitive pay information provided by Cook
as well as our current operating goals and environment to
determine the appropriate level and mix of incentive
compensation. Actual amounts earned from incentive compensation
are realized only as a result of individual or the
Corporations performance, depending on the type of award,
based on a comparison of actual results to pre-established goals.
Role
of Individual Pay Components
Executive compensation historically has been delivered
predominantly through base salary, annual cash bonuses,
long-term incentive awards as well as retirement programs and a
non-qualified deferred compensation plan.
Base
Salary
Base salaries are used to recognize an employees immediate
contribution to the organization, experience, knowledge, and
responsibilities of each particular role. Base salaries are also
used to compensate the Named Executive Officers for assuming a
significant level of responsibility, to provide financial
stability, to be market competitive, and to secure an
appropriate level of incentive.
According to our Salary Adjustment Policy (the
Policy) salary adjustments are based on a number of
relevant factors, including: particular importance of the
position to us, individual performance, growth in
19
position, market level increases, our financial performance and
ability to pay. Also, the Policy establishes that base pay
adjustments send clear performance messages and make moderate
distinctions based on performance; for executives, significant
distinctions in performance are recognized through our annual
cash program. In addition, this Policy requires that timing for
increases be consistent with market practice, and base salaries
for executives are reviewed and adjusted as necessary on an
annual basis to ensure pay levels remain competitive, as well as
the time of promotion or changes in responsibilities.
Annual
Cash Bonus
The annual cash bonus portion of an executives total
compensation opportunity is intended to accomplish a number of
objectives, including: reinforce the optimization of operating
results throughout the year, achievement of our stated
objectives; pay for performance and reinforce individual
accountability; support our long-term objective to create
shareholder value; and to provide market competitive cash
compensation when performance objectives are met or exceeded.
This bonus can be highly variable from year to year depending on
actual performance results.
The annual cash bonus is based on achievement of the
Corporations and individual business units goals
that are established at the beginning of each year. Goals are
approved by the Board and include financial goals, such as
consolidated premium earned and net income, as well as specific
performance goals for each Named Executive Officer. The annual
amount, if any, of the annual cash bonus is based on an
evaluation of each Named Executive Officers performance
and on the financial goal achievement. Depending on the
performance for the year, payment under the annual incentive may
range from 0 percent to 150 percent of the target
bonuses established by the Compensation Committee. The
Compensation Committee approves the awards and has discretion to
determine any changes to the amount to be paid. The final
recommendation of the Compensation Committee is approved by the
Board.
Target bonuses are currently established at 70 percent of
base salary for the Chief Executive Officer (CEO)
and from 50 percent to 70 percent for the other Named
Executive Officers. For the CEO and the Chief Financial Officer,
the financial performance goals are based 80 percent on the
Corporations actual financial performance, against the
corporate objectives for that year, and 20 percent on
non-financial performance. This includes individual objectives
that can be quantitative or qualitative. For all other executive
officers, the performance measures are based 30 percent on
the Corporations actual financial performance, against the
corporate objectives for that year, 50 percent on the
actual performance of the corresponding business unit for which
the executive is responsible, and 20 percent on the
executive officers non-financial performance, as
established by the Compensation Committee.
In addition, we pay an annual bonus each December to all of our
active employees, including the Named Executive Officers. This
bonus is determined based on a non-performance predetermined
formula and paid if the employee has worked more than
700 hours as of September 30 of each year and is an
employee at the date of payment. The amount paid under this
bonus approximates nine percent of base salary and, with respect
to the bonus payable to the Named Executive Officers, is
included in the bonus column of the Summary of Compensation
Table.
Long-Term
Incentive Awards
During 2007, on the closing of our initial public offering, we
awarded stock options, restricted stock awards and performance
awards to 11 executive officers, including Named Executive
Officers, under the Plan. We believe that long-term incentives
are an important and essential element that need to be offered
as part of the total compensation program of the Corporation as
a public entity to ensure our ability to attract, motivate, and
retain top talent. As such, our long-term incentives to key
management are designed to accomplish a number of important
objectives:
|
|
|
|
|
Align management and shareholder interests
|
|
|
|
Balance the short-term orientation of other compensation elements
|
20
|
|
|
|
|
Provide a variable portion of total compensation tied to
long-term market and financial performance of the Corporation
|
|
|
|
Build executive stock ownership
|
|
|
|
Hold executives accountable for their long-term decisions
|
|
|
|
Reinforce collaboration across the Corporation
|
|
|
|
Retain key executives over the long term
|
|
|
|
Share success with those who directly impact our performance
results
|
At the time of this award, the Compensation Committee determined
the terms of the award, including the performance period and the
performance objectives relating to the award of performance
shares. At the conclusion of a performance share award
performance period, the Compensation Committee will review
actual performance versus the pre-established performance goals
to determine whether the performance objectives were met in
whole or in part, and the associated payment that may be due as
a result. The Compensation Committee carefully considered the
impact of stock option expensing, as well as dilution, in order
to achieve a balance between our cost, competitiveness and
maintaining employee incentives.
The awards granted on the date of our initial public offering,
were intended to provide what we deem to be a proper and
competitive balance between stock options, restricted stock
awards and performance awards. Based on the fair value of the
awards determined in accordance with the Statement of Financial
Accounting Standards (SFAS) No. 123(R), Share-Based
Payment, approximately 51% of the cost of the grant was
delivered in stock options that only benefit participants when
the stock price increases, approximately 25% of the cost was
delivered in restricted stock awards, which allows us to retain
key talent over the long term, and the remaining 24% was
delivered in performance awards, which allows us to tie
compensation to the long-term market and financial performance
of the Corporation.
Future long-term incentives may be delivered through a variety
of award types that we may adopt in the future, including: stock
options, restricted stock/units, performance-based equity
(performance shares), performance-based cash (performance cash),
and other equity/non-equity award types (e.g., stock SARs/cash
SARs). We intend to provide long-term awards through a
combination of some of the above mentioned types of awards.
Retirement
Programs
Executive officers participate in our qualified and
non-qualified employee retirement programs designed to provide
retirement income. Our qualified and non-qualified pension plans
provide a retirement income base.
Non-Qualified
Deferred Compensation Plan
The purpose of this program is to provide certain executives who
elect to become participants with the opportunity of deferring a
portion of their compensation to a later date and benefiting
from the tax advantages related thereto.
Role of
Executive Officers in Compensation Decisions
The Compensation Committee makes all compensation decisions for
Named Executive Officers of the Corporation. Decisions regarding
the non-equity compensation of other executive officers are made
by the Chief Executive Officer. The CEO annually reviews the
performance of the other Named Executive Officer. The
conclusions reached and recommendations based on these reviews,
including with respect to salary adjustments and annual
incentive award amounts, are presented to the Compensation
Committee. The Compensation Committee reviews and approves or
recommends changes in the compensation of the Named Executive
Officers, including the CEO, and makes recommendations for final
approval to the Board.
21
Compensation
of Named Executive Officers for 2007
As part of the process of becoming a corporation whose shares
are publicly-traded, the Compensation Committee evaluated the
different components of compensation of the executive officers.
The purpose was to ascertain compensation at adequate levels
(defined as total compensation targeted at median external pay
levels) when compared with peer companies and to retain its
executive officers.
As part of the engagement of Cook, the Compensation Committee
reviewed each pay component to align compensation for the first
time to that of similar companies. The main purpose was to
assure that we established a competitive compensation program.
Based on the initial analysis, we began providing long-term
incentive awards during 2007.
Base
Salary
In setting base salaries for 2007, the Compensation Committee
considered the following factors:
|
|
|
|
|
The corporate budget, meaning our overall budget for base salary
increases. The corporate budget was established based on planned
performance for 2007. The objective of the budget is to allow
salary increases to retain and motivate successful performers
while maintaining affordability within our business plan.
|
|
|
|
The relative pay differences for different job levels.
|
|
|
|
Individual performance base salary increases were driven by
individual performance assessments.
|
|
|
|
Evaluation of peer group data specified to each executive
position, where applicable. However, the Compensation Committee
may exercise subjective judgment in determining final pay
recommendations.
|
In establishing Mr. Ruizs base salary for 2007, the
Compensation Committee applied the principles described above.
In an executive session, the Compensation Committee assessed
Mr. Ruizs 2006 performance, based on established
corporate goals and financial objectives. They considered the
Corporations and Mr. Ruizs accomplishment of
objectives that had been established at the beginning of the
year, strategic direction of the Corporation and its own
subjective assessment of his performance. The Compensation
Committee approved the salary increase of Mr. Ruiz and
recommended it to the Board, which also approved it.
For all other Named Executive Officers salary increases were
based on the aforementioned principles and were in line with
budget increases.
Long-Term
Incentive Awards
On the closing date of our initial public offering, the
Compensation Committee awarded certain executive officers,
including Named Executive Officers, stock options, restricted
stock awards and performance awards. A summary of the long-term
incentive awards granted during 2007 is included on the Grants
of Plan Based Awards table.
Non-Equity
Incentive Plan
The non-equity incentive award for 2007 was based on the
performance of the Corporation against the stated objectives.
For 2007, our reported net income was $58.5 million, which
exceeded the targeted level and reached the superior level.
Also, total operating revenues, excluding net investment income,
was $1.5 billion, which was just at targeted level.
In February 2008, the Compensation Committee and the Board
approved payments to the Named Executive Officers under the 2007
non-equity incentive plan, in the amounts set-forth below in the
Summary Compensation Table. Payments were made within the
parameters established.
22
Compensation
Committee Report
The Corporations Compensation Committee has reviewed and
discussed the Compensation Discussion and Analysis required
above with management and, based on such review and discussions,
the Compensation Committee recommended to the Board that the
Compensation Discussion and Analysis be included in this proxy
statement.
Submitted by:
Adamina Soto-Martínez, CPA, Chair of the Compensation
Committee
Carmen Ana Culpeper-Ramírez
Vicente J. León-Irizarry, CPA
Manuel Figueroa-Collazo
Jaime Morgan-Stubbe
Miguel Nazario-Franco
Summary
Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and Non-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
Name and Principal Position
|
|
Year
|
|
|
Salary(1)
|
|
|
Bonus(2)
|
|
|
Awards(3)
|
|
|
Awards(3)
|
|
|
Compensation
|
|
|
Earnings(4)
|
|
|
Compensation(5)
|
|
|
Total
|
|
|
Ramón M. Ruiz-Comas,
|
|
|
2007
|
|
|
$
|
541,500
|
|
|
$
|
49,838
|
|
|
$
|
51,370
|
|
|
$
|
51,301
|
|
|
$
|
431,000
|
|
|
$
|
120,000
|
|
|
$
|
91,924
|
|
|
$
|
1,336,933
|
|
President and CEO Triple-S
|
|
|
2006
|
|
|
|
492,274
|
|
|
|
45,325
|
|
|
|
|
|
|
|
|
|
|
|
386,020
|
|
|
|
115,000
|
|
|
|
72,868
|
|
|
|
1,111,487
|
|
Management Corporation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Juan José Román-Jiménez,
|
|
|
2007
|
|
|
|
360,000
|
|
|
|
33,200
|
|
|
|
17,123
|
|
|
|
17,100
|
|
|
|
206,800
|
|
|
|
60,000
|
|
|
|
27,014
|
|
|
|
721,237
|
|
Vice President of Finance &
|
|
|
2006
|
|
|
|
285,000
|
|
|
|
26,325
|
|
|
|
|
|
|
|
|
|
|
|
165,758
|
|
|
|
35,000
|
|
|
|
21,474
|
|
|
|
533,557
|
|
CFO of Triple-S Management Corporation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Socorro Rivas-Rodríguez,
|
|
|
2007
|
|
|
|
395,700
|
|
|
|
36,473
|
|
|
|
17,123
|
|
|
|
17,100
|
|
|
|
325,400
|
|
|
|
105,000
|
|
|
|
65,908
|
|
|
|
962,704
|
|
President of Triple-S, Inc.
|
|
|
2006
|
|
|
|
380,500
|
|
|
|
35,079
|
|
|
|
|
|
|
|
|
|
|
|
299,895
|
|
|
|
175,000
|
|
|
|
67,595
|
|
|
|
958,069
|
|
Eva G. Salgado,
|
|
|
2007
|
|
|
|
275,700
|
|
|
|
25,473
|
|
|
|
5,137
|
|
|
|
5,130
|
|
|
|
221,800
|
|
|
|
54,000
|
|
|
|
33,406
|
|
|
|
620,646
|
|
President of Seguros Triple-S, Inc.
|
|
|
2006
|
|
|
|
264,500
|
|
|
|
24,446
|
|
|
|
|
|
|
|
|
|
|
|
207,664
|
|
|
|
48,000
|
|
|
|
28,802
|
|
|
|
573,412
|
|
Luis A. Marini-Mir,
|
|
|
2007
|
|
|
|
232,600
|
|
|
|
21,522
|
|
|
|
2,397
|
|
|
|
2,394
|
|
|
|
158,000
|
|
|
|
49,000
|
|
|
|
31,850
|
|
|
|
497,763
|
|
President of Triple-C, Inc.
|
|
|
2006
|
|
|
|
223,700
|
|
|
|
20,706
|
|
|
|
|
|
|
|
|
|
|
|
138,856
|
|
|
|
48,000
|
|
|
|
40,782
|
|
|
|
472,044
|
|
|
|
|
(1) |
|
Amounts represent base salary. Some of the Named Executive
Officers deferred a portion of their salary under the
non-qualified deferred salary plan, which was included in the
Non-Qualified Deferred Compensation Table. |
|
(2) |
|
Represents annual non-performance base bonus. See to the
Compensation Discussion and Analysis Annual
Cash Bonus for detailed explanation. |
|
(3) |
|
The amounts in this column reflect the dollar amount recognized
for financial statement reporting purposes with respect to the
year ended December 31, 2007 in accordance with the
provisions SFAS No. 123(R), excluding the estimated
forfeitures related to service-based vesting conditions. |
|
(4) |
|
The amounts represent the actuarial increase in the present
value of the Named Executive Officers benefits under our
pension plan, and the Supplemental Benefit Plan, further
described below. The increase was calculated using the interest
rate, discount rate and form of payment assumptions consistent
with those used in our financial statements. The calculation
assumes benefit commencement is at normal retirement age (65),
and was calculated without respect to pre-retirement death,
termination or disability. Earnings on deferred compensation are
not reflected in this column because we do not provide above
market or guarantee returns on non-qualified deferred
compensation. |
|
(5) |
|
Other annual compensation consists of the following: |
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sick Leave &
|
|
|
|
|
|
|
|
Name
|
|
Vehicles Allowance
|
|
|
Vacation Paid(a)
|
|
|
Other
|
|
|
Total
|
|
|
Ramón M. Ruiz-Comas
|
|
$
|
17,723
|
|
|
$
|
74,201
|
|
|
$
|
|
|
|
$
|
91,924
|
|
Juan José Román-Jiménez
|
|
|
|
|
|
|
27,014
|
|
|
|
|
|
|
|
27,014
|
|
Socorro Rivas-Rodríguez
|
|
|
22,415
|
|
|
|
38,570
|
|
|
|
4,923
|
|
|
|
65,908
|
|
Eva G. Salgado
|
|
|
12,760
|
|
|
|
20,646
|
|
|
|
|
|
|
|
33,406
|
|
Luis A. Marini-Mir
|
|
|
15,993
|
|
|
|
12,390
|
|
|
|
3,467
|
|
|
|
31,850
|
|
|
|
|
(a) |
|
We pay to all of our employees, including the Named Executive
Officers, the sick leave license days not used during the year
and the excess, if any, of vacation accrued over thirty days.
Amounts included represent cash paid during 2007. |
Grants of
Plan-Based Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
Option
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Awards:
|
|
|
|
|
|
Date Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Number of
|
|
|
Exercise
|
|
|
Value of
|
|
|
|
|
|
|
Estimated Future Payments Under Non-
|
|
|
Estimated Future Payments Under
|
|
|
Number of
|
|
|
Securities
|
|
|
Price of
|
|
|
Stock and
|
|
|
|
|
|
|
Equity Incentive Plan Awards(1)
|
|
|
Equity Incentive Plan Awards
|
|
|
Shares of
|
|
|
Underlying
|
|
|
Option
|
|
|
Option
|
|
Name
|
|
Grant Date
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Stock (#)
|
|
|
Options (#)
|
|
|
Awards(2)
|
|
|
Awards(3)
|
|
|
Ramón M. Ruiz-Comas
|
|
|
|
|
|
$
|
303,240
|
|
|
$
|
379,050
|
|
|
$
|
568,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/7/2007
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
465,517
|
|
|
$
|
14.50
|
|
|
$
|
4.83
|
|
|
|
|
12/7/2007
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77,586
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
12/7/2007
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,793
|
|
|
|
77,586
|
|
|
|
155,172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
Juan José Román-Jiménez
|
|
|
|
|
|
|
144,000
|
|
|
|
180,000
|
|
|
|
270,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/7/2007
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155,172
|
|
|
|
14.50
|
|
|
|
4.83
|
|
|
|
|
12/7/2007
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,862
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
12/7/2007
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,931
|
|
|
|
25,862
|
|
|
|
51,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
Socorro Rivas-Rodríguez
|
|
|
|
|
|
|
231,890
|
|
|
|
289,860
|
|
|
|
434,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/7/2007
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155,172
|
|
|
|
14.50
|
|
|
|
4.83
|
|
|
|
|
12/7/2007
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,862
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
12/7/2007
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,931
|
|
|
|
25,862
|
|
|
|
51,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
Eva G. Salgado
|
|
|
|
|
|
|
153,340
|
|
|
|
191,680
|
|
|
|
287,520
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/7/2007
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,552
|
|
|
|
14.50
|
|
|
|
4.83
|
|
|
|
|
12/7/2007
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,759
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
12/7/2007
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,880
|
|
|
|
7,759
|
|
|
|
15,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
Luis A. Marini-Mir
|
|
|
|
|
|
|
102,340
|
|
|
|
127,930
|
|
|
|
191,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/7/2007
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,724
|
|
|
|
14.50
|
|
|
|
4.83
|
|
|
|
|
12/7/2007
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,621
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
12/7/2007
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,811
|
|
|
|
3,621
|
|
|
|
7,242
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.50
|
|
|
|
|
(1) |
|
The Compensation Committee established the performance measures
for purposes of determining the amounts payable for the year
ended December 31, 2007. The amounts shown under the
Threshold column assume that the lowest levels meet by the
Corporation or business unit. The amount of the annual bonus can
be zero if the lowest level is not achieved. Awards, if any,
under this plan are payable in the first quarter of the
following year. Amounts approved for 2007 are reflected in the
Summary Compensation Table Non-Equity Incentive Plan
Compensation column. |
|
(2) |
|
All stock options were granted at an exercise price equal to the
offering price on the New York Stock Exchange of our
Class B shares. |
|
(3) |
|
The grant date fair value of these awards was calculated in
accordance with the provisions SFAS No. 123(R). There
is no assurance that the value realized by Named Executive
Officers, if any, will be at or near the amounts shown in this
column. Future compensation resulting from option grants will be
based solely on the performance of our stock price. |
|
(4) |
|
Represents the number of stock options granted on the date of
our initial public offering under the Plan. |
|
(5) |
|
Represents the number of restricted stocks awarded on the date
of our initial public offering under the Plan. Restricted stocks
were considered issued and outstanding as of December 31,
2007, however, they |
24
|
|
|
|
|
have a three year vesting period. Restricted stocks have the
right as any other shareholder to receive any dividend declared
by the Corporation on its Class B shares. |
|
(6) |
|
Represents the number of performance awards granted on the date
of our initial public offering under the Plan. Performance
awards vest at the end of a three-year period only if
performance measures were achieved by Named Executive Officers.
The threshold payout was determined at 50% of target and the
maximum payout was determined at 200% of target. Performance
measures have not been determined yet by the Compensation
Committee. |
Outstanding
Equity Awards at Fiscal Year-End
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
Incentive Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Plan
|
|
|
|
|
|
|
Number of
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Awards:
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Market
|
|
|
Number of
|
|
|
Market
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares of
|
|
|
Value of
|
|
|
Unearned
|
|
|
Value of
|
|
|
|
Underlying
|
|
|
Exercise
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
Stock That
|
|
|
Shares of
|
|
|
Shares
|
|
|
Unearned
|
|
|
|
Exercise
|
|
|
Options (#)
|
|
|
Unexercised
|
|
|
Option
|
|
|
Option
|
|
|
Have Not
|
|
|
Stock That
|
|
|
That Have
|
|
|
Shares That
|
|
|
|
Options (#)
|
|
|
Unexercisable
|
|
|
Unearned
|
|
|
Exercise
|
|
|
Expiration
|
|
|
Vested (#)
|
|
|
Have Not
|
|
|
Not Vested
|
|
|
Have Not
|
|
Name
|
|
Exercisable
|
|
|
(1)
|
|
|
Options (#)
|
|
|
Price
|
|
|
Date
|
|
|
(2)
|
|
|
Vested(3)
|
|
|
(#)(4)
|
|
|
Vested(3)
|
|
|
Ramón M. Ruiz-Comas
|
|
|
|
|
|
|
465,517
|
|
|
|
|
|
|
$
|
14.50
|
|
|
|
12/7/2014
|
|
|
|
77,586
|
|
|
$
|
1,568,013
|
|
|
|
77,586
|
|
|
$
|
1,568,013
|
|
Juan José Román-Jiménez
|
|
|
|
|
|
|
155,172
|
|
|
|
|
|
|
|
14.50
|
|
|
|
12/7/2014
|
|
|
|
25,862
|
|
|
|
522,671
|
|
|
|
25,862
|
|
|
|
522,671
|
|
Socorro Rivas-Rodríguez
|
|
|
|
|
|
|
155,172
|
|
|
|
|
|
|
|
14.50
|
|
|
|
12/7/2014
|
|
|
|
25,862
|
|
|
|
522,671
|
|
|
|
25,862
|
|
|
|
522,671
|
|
Eva G. Salgado
|
|
|
|
|
|
|
46,552
|
|
|
|
|
|
|
|
14.50
|
|
|
|
12/7/2014
|
|
|
|
7,759
|
|
|
|
156,809
|
|
|
|
7,759
|
|
|
|
156,809
|
|
Luis A. Marini-Mir
|
|
|
|
|
|
|
21,724
|
|
|
|
|
|
|
|
14.50
|
|
|
|
12/7/2014
|
|
|
|
3,621
|
|
|
|
73,180
|
|
|
|
3,621
|
|
|
|
73,180
|
|
|
|
|
(1) |
|
Stock option awards vest in equal installments on
December 7, 2008, December 7, 2009 and
December 7, 2010. |
|
(2) |
|
Unvested restricted stock grants vest in equal installments on
December 7, 2008, December 7, 2009 and
December 7, 2010. |
|
(3) |
|
The market value of restricted stock and performance awards that
have not vested was calculated by multiplying the closing price
of our Class B shares on December 31, 2007 ($20.21),
by the applicable number of shares. |
|
(4) |
|
Unvested performance awards vest on December 31, 2010
depending on the achievement of performance measures by Named
Executive Officers. |
25
Defined
Benefit Retirement Plan
The following table illustrates the present value of accumulated
benefits and the number of years credited service for the Named
Executive Officers under our Non-Contributory Retirement Program
and our Supplemental Retirement Program.
Pension
Benefits Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
Present
|
|
|
|
|
|
|
|
|
of Years
|
|
|
Value of
|
|
|
Payments
|
|
|
|
|
|
Credited
|
|
|
Accumulated
|
|
|
During Last
|
|
Name
|
|
Plan Name
|
|
Service
|
|
|
Benefit
|
|
|
Fiscal Year
|
|
|
Ramón M. Ruiz-Comas
|
|
Non-Contributory Retirement Program for Certain Employees of
Triple-S Management Corporation
|
|
|
17.56
|
|
|
$
|
395,000
|
|
|
|
|
|
|
|
Triple-S Management Corporation Supplemental Retirement Program
|
|
|
|
|
|
|
525,000
|
|
|
|
|
|
Juan José Román-Jiménez
|
|
Non-Contributory Retirement Program for Certain Employees of
Triple-S Management Corporation
|
|
|
11.98
|
|
|
|
165,000
|
|
|
|
|
|
|
|
Triple-S Management Corporation Supplemental Retirement Program
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
Socorro Rivas-Rodríguez(1)
|
|
Non-Contributory Retirement Program for Certain Employees of
Triple-S Management Corporation
|
|
|
25.97
|
|
|
|
955,000
|
|
|
|
|
|
|
|
Triple-S Management Corporation Supplemental Retirement Program
|
|
|
|
|
|
|
725,000
|
|
|
|
|
|
Eva G. Salgado
|
|
Non-Contributory Retirement Program for Certain Employees of
Triple-S Management Corporation
|
|
|
11.89
|
|
|
|
240,000
|
|
|
|
|
|
|
|
Triple-S Management Corporation Supplemental Retirement Program
|
|
|
|
|
|
|
45,000
|
|
|
|
|
|
Luis A. Marini-Mir(1)
|
|
Non-Contributory Retirement Program for Certain Employees of
Triple-S Management Corporation
|
|
|
9.91
|
|
|
|
345,000
|
|
|
|
|
|
|
|
Triple-S Management Corporation Supplemental Retirement Program
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
(1) |
|
Participant is eligible for early retirement under both plans.
Additional details on early retirement payments and benefit
formula and eligibility standards can be found in the sections
titled Non-Contributory Defined Benefit Pension Plan
and Supplementary Retirement Plan below. |
We sponsor a Non-Contributory Retirement Program for certain of
our employees. The compensation covered by the pension plans is
the annual salary as set forth in the Summary Compensation
Table. The Supplemental Retirement Program covers benefits in
excess of the Internal Revenue Service (IRS) limits
that apply to the Non-Contributory Retirement Program, which is
a qualified program under IRS rules. The following is a summary
of the pension plans provisions.
Non-Contributory
Defined-Benefit Pension Plan
|
|
|
|
|
Employees eligible for participation
Employees age 21 or older with one year of service with
a Blue Cross
and/or Blue
Shield organization are eligible to participate. An employee
becomes a Participant on the January 1 or July 1 coincident with
or next following the completion of the age and service
participation requirements.
|
26
Employees of a subsidiary that participate in this Program are
treated as employees of the Sponsoring Employer for purposes of
this Program.
|
|
|
|
|
Average earnings Highest average
annual rate of pay from any five consecutive calendar year
periods out of the last ten years. Each years earnings are
limited to $200,000 (as indexed). As permitted under the
Economic Growth and Tax Relief Reconciliation Act of 2001
(EGTRRA), for purposes of calculating Final Average
Earnings for participants who are employed on or after
January 1, 2002, the $200,000 limit applied retroactively
to the 1994 Program year. For 2007, the pension earnings are
limited to $225,000.
|
|
|
|
Accrued benefit Single life benefit equal to
the following:
|
i. 2% of Final Average Earnings multiplied by Plan and
Association Service (defined as years worked by an employee
working with the BCBSA)
ii. up to 30 years, minus
iii. Prior Plan benefit (if any)
The Accrued Benefit cannot be less than the benefit calculated
considering Employer Service only.
iv. Eligibility Termination of
employment after both the attainment of age 65 and after
either the fifth anniversary of Program participation or
completion of five years of Vesting Service.
v. Benefit The Accrued Benefit
payable at Normal Retirement Date.
To be eligible for early retirement, termination of employment
should occur after attaining age 55 with five years of Plan
Service. The benefit will be the Accrued Benefit at Normal
Retirement Date reduced using factors that are actuarially
equivalent to the age 62 benefit. There is no reduction if
retirement occurs after age 62.
The Plan also has a special early retirement. To be eligible,
the termination of employment should occur after attaining
30 years of Plan Service and election of immediate benefit
commencement. The Accrued Benefit is calculated at date of
termination with no early retirement reductions. This benefit
replaces the Early Retirement benefit for those meeting the
Special Early Retirement benefit eligibility.
|
|
|
|
|
Forms of payment The standard form is
a straight life annuity. The automatic form of payment for a
single Participant is the standard form, and for a married
Participant at the benefit commencement date there is a reduced
qualified joint and survivor annuity, with 50% of the benefit
continuing to the surviving spouse upon the earlier death of the
Participant.
|
In lieu of the automatic form of payment, a Participant may
elect, with the proper spousal consent, one of the optional
forms of annuity payment or, alternatively, a single lump sum
payment.
Supplementary
Retirement Plan
|
|
|
|
|
Employees eligible for participation
Employees with Qualified Retirement Program (the
Non-Contributory Retirement Program) benefits
limited by the IRC maximum compensation and benefit limits are
eligible to participate.
|
|
|
|
Final average earnings The highest
average annual rate of pay from any five consecutive calendar
year periods out of the last ten years.
|
|
|
|
Accrued benefit Single life benefit
equal to the following:
|
vi. 2% of Final Average Earnings multiplied by Plan and
Association Service up to 30 years, minus
vii. Prior Plan benefit (if any), minus
27
viii. Qualified Retirement Program Benefit
The Accrued Benefit cannot be less than the benefit calculated
considering Employer Service only.
ix. Eligibility Termination of
employment after both the attainment of age 65 and after
either the fifth anniversary of Program participation or
completion of five years of Vesting Service.
x. Benefit The Accrued Benefit
payable at Normal Retirement Date.
xi. Eligibility Termination of
employment after attaining age 55 with five years of Plan
and Association Service.
xii. Benefit The Accrued Benefit
at Normal Retirement Date reduced using factors that are
actuarially equivalent to the age 62 benefit. No reduction
if retirement occurs after age 62.
|
|
|
|
|
Special early retirement
|
xiii. Eligibility Termination of
employment after attaining 30 years of Plan and Association
Service and election of immediate benefit commencement.
xiv. Benefit This benefit replaces the
Early Retirement benefit for those meeting the Special Early
Retirement benefit eligibility.
|
|
|
|
|
Forms of payment The standard form is
a straight life annuity. The automatic form of payment for a
single Participant is the standard form and for a married
Participant at the benefit commencement date is a reduced
qualified joint and survivor annuity, with 50% of the benefit
continuing to the surviving spouse upon the earlier death of the
Participant.
|
Non-Qualified
Deferred Compensation Table
The following table presents the non-qualified deferred
compensation for the Named Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
|
Registrant
|
|
|
Aggregate
|
|
|
|
|
|
Aggregate
|
|
|
|
Contribution
|
|
|
Contribution
|
|
|
Earnings in
|
|
|
Aggregate
|
|
|
Balance at
|
|
|
|
Last Fiscal
|
|
|
in Last Fiscal
|
|
|
Last Fiscal
|
|
|
Withdrawals/
|
|
|
Last Fiscal
|
|
Name
|
|
Year(1)
|
|
|
Year
|
|
|
Year
|
|
|
Distributions
|
|
|
Year
|
|
|
Ramón M. Ruiz
|
|
$
|
13,200
|
|
|
|
|
|
|
$
|
11,461
|
|
|
|
|
|
|
$
|
253,189
|
|
Juan J. Román
|
|
|
56,000
|
|
|
|
|
|
|
|
5,796
|
|
|
|
|
|
|
|
142,502
|
|
Socorro Rivas
|
|
|
50,102
|
|
|
|
|
|
|
|
52,316
|
|
|
|
|
|
|
|
1,159,456
|
|
Eva G. Salgado
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Luis A. Marini
|
|
|
30,000
|
|
|
|
|
|
|
|
13,260
|
|
|
|
|
|
|
|
299,989
|
|
(1) Amounts included in this column are reported as
compensation in the Summary Compensation Table.
Participants may elect to defer up to twenty percent (20%) of
gross annual cash compensation under the Program. They forfeit
all rights to the compensation deferred until the occurrence of
any of the following events:
|
|
|
|
|
Upon termination of employment
|
|
|
|
Retirement
|
|
|
|
Six (6) months of continued disability
|
|
|
|
Death of Participant
|
|
|
|
An elected fixed date occurring after the 5th but not later
than the 25th anniversary of deferral
|
28
2007
Incentive Plan
Please refer to Proposal #4 for information regarding the
Plan.
DIRECTORS
COMPENSATION AND BENEFITS
Effective July 1, 2007, we revised the compensation
structure for members of our Board. Under our new
directors compensation structure, the Chairman of the
Board receives a monthly retainer of $6,500 and all other Board
members receive a monthly retainer of $2,500. The Chairman of
the Audit Committee receives an additional monthly retainer of
$416.66, and the respective Chairmen of the Compensation,
Corporate Governance, and Nominations Committees receive an
additional monthly retainer of $250. The following is the amount
received by each director for Board or committee meetings:
|
|
|
|
|
Meetings
|
|
Director
|
|
|
Board of Directors
|
|
$
|
500
|
|
Audit Committee
|
|
|
350
|
|
Corporate Governance, Compensation and Nominations Committees
|
|
|
300
|
|
All other
|
|
|
150
|
|
In addition, all Board members receive $522.15 as a monthly
stipend for health insurance. Directors who are also employees
do not receive any compensation for service, as members of the
Board or any committee of the Board, or the board of directors
of a subsidiary.
The following tables summarize the fees or other compensation
that our directors earned for services as members of the Board
or any committee of the Board during 2007, pursuant to our
outstanding compensation structures.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
All Other
|
|
|
|
|
Name
|
|
Paid in Cash(1)
|
|
|
Compensation(2)
|
|
|
Total
|
|
|
Wilmer Rodríguez-Silva, M.D.
|
|
$
|
78,511
|
|
|
$
|
5,566
|
|
|
$
|
84,077
|
|
Vicente J. León-Irizarry, C.P.A
|
|
|
46,661
|
|
|
|
5,821
|
|
|
|
52,482
|
|
Miguel Nazario-Franco
|
|
|
42,411
|
|
|
|
5,821
|
|
|
|
48,232
|
|
Adamina Soto-Martínez, C.P.A
|
|
|
42,411
|
|
|
|
2,641
|
|
|
|
45,052
|
|
Jesús R. Sánchez-Colón, D.M.D
|
|
|
39,261
|
|
|
|
5,566
|
|
|
|
44,827
|
|
José Arturo Alvarez-Gallardo
|
|
|
38,111
|
|
|
|
5,821
|
|
|
|
43,932
|
|
Manuel Figueroa-Collazo, P.E
|
|
|
36,846
|
|
|
|
5,821
|
|
|
|
42,667
|
|
Luis A. Clavell, M.D.
|
|
|
36,311
|
|
|
|
5,821
|
|
|
|
42,132
|
|
Carmen Ana Culpeper-Ramírez
|
|
|
39,361
|
|
|
|
2,641
|
|
|
|
42,002
|
|
Juan E. Rodríguez Díaz
|
|
|
35,561
|
|
|
|
5,821
|
|
|
|
41,382
|
|
José Hawayek-Alemañy, M.D.
|
|
|
35,784
|
|
|
|
5,566
|
|
|
|
41,350
|
|
Porfirio E. Díaz-Torres, M.D.
|
|
|
35,261
|
|
|
|
5,821
|
|
|
|
41,082
|
|
Valeriano Alicea-Cruz, M.D.
|
|
|
34,911
|
|
|
|
5,821
|
|
|
|
40,732
|
|
Wilfredo López-Hernández, M.D.
|
|
|
34,802
|
|
|
|
5,821
|
|
|
|
40,623
|
|
Arturo Córdova-López, M.D.
|
|
|
34,061
|
|
|
|
5,566
|
|
|
|
39,627
|
|
Antonio F. Faria(3)
|
|
|
30,911
|
|
|
|
5,821
|
|
|
|
36,732
|
|
Roberto Muñoz-Zayas(3)
|
|
|
28,111
|
|
|
|
5,821
|
|
|
|
33,932
|
|
Jaime Morgan-Stubbe(3)
|
|
|
28,211
|
|
|
|
5,566
|
|
|
|
33,777
|
|
Fernando J. Ysern-Borrás, M.D.(4)
|
|
|
11,734
|
|
|
|
3,711
|
|
|
|
15,445
|
|
Mario S Belaval(4)
|
|
|
11,800
|
|
|
|
3,521
|
|
|
|
15,321
|
|
Manuel Suárez-Méndez(4)
|
|
|
8,850
|
|
|
|
3,521
|
|
|
|
12,371
|
|
29
|
|
|
(1) |
|
Prior to July 1, 2007, directors who were not employees
were paid an annual fee of $8,000 as directors of the
Corporation and $7,000 as directors of Triple-S, Inc. The
Chairmen of the Boards of the Corporation and Triple-S, Inc.
received an annual retainer of $10,500 and $9,500, respectively.
Directors received these fees on a pro rated basis for the first
half of 2007. The following is the amount received by each
director for Board or committee meetings prior to July 1,
2007: |
|
|
|
|
|
|
|
|
|
Meetings
|
|
Chairman
|
|
|
Director
|
|
|
Board of Directors of Triple-S Management Corporation and
Triple-S, Inc.
|
|
$
|
200
|
|
|
$
|
200
|
|
Audit Committee
|
|
|
350
|
|
|
|
250
|
|
Other Committees of Triple-S Management Corporation
|
|
|
300
|
|
|
|
200
|
|
Other Subsidiaries Boards and Committees
|
|
|
250
|
|
|
|
150
|
|
|
|
|
(2) |
|
Represents the cost of a healthcare plan for the director and
his/her spouse and children until June 30, 2007. Effective
July 1, 2007, this policy was discontinued and all board
members now receive a monthly stipend of $522.15 for health
insurance. The monthly stipend for health insurance is included
within the Fees Earned or Paid in Cash column. |
|
|
|
In addition, the Board holds an annual off-site meeting to
discuss our strategic direction and to comply with educational
requirements, among other purposes. Members may be accompanied
by their spouses, whose transportation and other costs are paid
by us. Certain executives and their spouses accompany the Board
as it may be necessary. Some of the activities at this meeting
could be considered non-work related; however, due to the
difficulty in allocating the specific cost to each member and
since total cost is estimated at less than $5,000 per person,
such amount was not included in the above table under All
Other Compensation. |
|
(3) |
|
Term as member of the Board began on April 30, 2007. |
|
(4) |
|
Term as member of the Board expired on April 29, 2007. |
* * *
OTHER
RELATIONSHIPS, TRANSACTIONS AND EVENTS
Certain directors and executive officers of the Corporation have
immediate family members who are employed by the Corporation or
its subsidiaries. The compensation of these family members is
established in accordance with the employment and compensation
practices applicable to employees with equivalent qualifications
and responsibilities and holding similar positions.
In the ordinary course of business, the Corporations
subsidiaries provide insurance to a number of individual
directors and executive officers of the Corporation, to the
medical practices of such directors, and to members of their
respective immediate families. The Corporations
subsidiaries also provide insurance to
Méndez & Co., Inc., Menaco Corporation,
Clínica Las Américas Guaynabo, Palmas del Mar
Properties, Inc., B. Fernández & Hermanos, Inc.,
Pan Pepin (a wholly-owned subsidiary of B Fernandez &
Hermanos Holding), Kevane Grant Thorton, LLP,
San Jorge Medical Specialties and Vernet, Inc.
Certain directors and nominees have material ownership interests
in or occupy senior positions at these entities, including as
President and Director. The aggregate amount paid to the
Corporations subsidiaries for services to these entities
in 2007 amounted to approximately $3,734,788. The terms on which
the Corporations subsidiaries provide insurance to related
parties are substantially the same as the terms offered to
unrelated parties.
Directors of the Corporation that are physicians, dentists or
their affiliated entities are also service providers of
Triple-S, Inc. in the ordinary course of their business as
physicians and dentists. Some of our directors, their immediate
family members and affiliated entities received more than
$120,000 in compensation for services as healthcare providers
for one of the Corporations subsidiaries. Dr. Wilmer
Rodríguez-Silva, chairman of the Board, received
approximately $191,430 in 2007. Dr. Porfirio
Díaz-Torres, a director of our Board, and members of his
immediate family received approximately $374, 161 in 2007.
Clínica Las Américas Guaynabo, a medical clinic
of which our director, Dr. Arturo Córdova-López,
is Medical Director and a
30
principal shareholder, received total payments from Triple-S,
Inc. of approximately $1,950,593 in 2007. San Jorge
Childrens Medical Specialties, a medical group of
which our director, Dr. Luis A. Clavell-Rodríguez, is
the managing partner and controlling shareholder, received total
payments from Triple-S, Inc of approximately $540,684 in 2007.
San Jorge Childrens Hospital, a hospital at
which Dr. Luis A. Clavell-Rodríguez is the Chief
Medical Officer, received total payments from TSI of
approximately $10,207,699 in 2007. The terms of the provider
agreements with Triple-S, Inc. pursuant to which the above
payments were made are the same as the terms of the provider
agreements of physicians and healthcare organizations who are
not directors or affiliated with directors of the Corporation.
While the Corporation periodically monitors transactions with
related persons, the Corporation has not adopted a formal
written policy regarding the review, approval or ratification of
transactions with related persons. On an annual basis, each
director and executive officer of the Corporation is obligated
to complete a Director and Officer Questionnaire which requires
disclosure of any transactions with the Corporation in which the
director or executive officer, or any member of his or her
immediate family, have a direct or indirect material interest.
* * *
AMENDMENTS
TO THE AMENDED AND RESTATED ARTICLES OF
INCORPORATION
On February 28, 2008, our Board adopted resolutions
approving the amendments to the Articles, and recommended that
they be presented for shareholder approval at the annual meeting
of shareholders, as required by the Articles. The adoption of
the amendments to the Articles would modify the composition of
the three groups into which our Board is divided, making them
more consistent with those contained in the articles of
incorporation of comparable publicly-traded companies and the
requirements of the BCBSA. For the reasons set forth below, our
Board believes that it is in the best interest of the
Corporation and that of its shareholders to adopt the amendments
to the Articles (Proposals 2 and 3).
Currently, the Articles of the Corporation establish that the
Board shall be divided into three groups, consisting of five
(5), six (6) and seven (7) directors, respectively.
Although our By-laws provide that our Board may determine its
size by resolution, the current staggered board provision
included in our Articles prevents our Board from exercising the
authority granted to it by our By-laws. Our Board believes that
it should be afforded the flexibility currently provided by our
By-laws, which in turn, will enable it to make decisions
regarding its effectiveness and productivity.
During the 2008 Annual Meeting of Shareholders, a proposal for
adopting certain amendments to our Articles will be presented.
Our Board believes that the amendments present changes that are
important to the continued improvement of its performance.
PROPOSAL 2:
AMENDMENT OF ARTICLE TENTH B OF THE AMENDED AND RESTATED
ARTICLES OF INCORPORATION
Proposal 2 is presented by the Board to amend
Article TENTH B of our Articles. Proposal 2 eliminates
the requirement that each group of directors be comprised of a
specific number of directors and authorizes the Board to make
certain changes regarding the size of each group of the Board.
TENTH:
B. Subject to the terms of this paragraph,
The the Board of
Directors is shall be divided
into three groups, plus the President of the
Corporation, respectively designated Group
1, Group 2, and Group 3, as nearly
equal in number as possible and whose term expire at different
times. Directors in each group shall be elected for a term
ending on the date of the third annual meeting of shareholders
following the annual meeting at which such director is elected.
The Board of Directors may (i) reduce the size of each
group of directors and (ii) nominate directors for shorter
terms of office and assign such nominees to another group, in
order to meet the requirements of the first sentence of this
paragraph by
31
the 2010 annual meeting of shareholders. The
first is made up of five (5) directors, the second group is
composed of six (6) directors, and the third group is made
up of seven (7) directors. The terms of the groups will be
placed at intervals, therefore, the term of the first group of
directors will end in the Shareholders Annual Meeting in the
year 2005; the term of the second group of directors will end in
the Shareholders Annual Meeting in the year 2006 and the term of
the third group of directors will end in the Shareholders Annual
Meeting in the year 2007.
Reasons
for Voting in Favor of the Proposal
Our Board may determine its size by resolution pursuant to an
amendment to our Articles approved in the 2007 Annual Meeting of
Shareholders. Our Articles provide, however, that our Board must
be comprised of at least nine (9) directors but no more
than nineteen (19). Our Board is currently comprised of nineteen
(19) directors.
Our Board has considered the advantages and disadvantages of its
current size. In connection with the 2008 Annual Meeting of
Shareholders, the Board has approved a resolution to reduce the
number of directors from nineteen (19) to seventeen (17).
The Corporation will achieve this reduction by proposing three
(3) nominees to fill the five (5) vacancies up for
election by shareholders at the 2008 annual meeting of
shareholders. The Board also has voted to approve
Proposal 2, which amends Article TENTH B of the
Articles in order to provide flexibility in the determination of
the size of each of the groups into which our Board is divided,
and recommends it to our shareholders as being in the best
interest of the Corporation and our shareholders. In reaching
this determination, our Board concluded that the flexibility and
added efficiency that a smaller board of directors provides a
company whose shares are publicly-traded outweighed the benefits
of a larger board of directors.
At present, our Articles establish that the Board shall be
divided into three groups, consisting of five (5), six
(6) and seven (7) directors, respectively. Upon the
approval by our shareholders of Proposal 2, the Board
resolution reducing the amount of directors serving on our Board
will take effect. Our Board will reduce the size of each group
of directors in the manner it deems appropriate and nominate
sufficient directors to fill the remaining vacancies in each
group at annual meetings of shareholders following the 2008
annual meeting of shareholders. This process will begin at the
2008 annual meeting of shareholders and will be completed at the
2010 annual meeting of shareholders.
Vote
Requirement
The affirmative vote of the majority of the issued and
outstanding shares of common stock entitled to vote on the
record date is required to approve the amendment to
Article TENTH B of the Articles. This reduced vote
requirement is due to the approval by the BCBSA of this
Proposal 2.
The Board believes that the proposal to approve the amendment
to Article TENTH B of the Articles is in the best interests
of our shareholders and recommends a vote FOR the proposal.
PROPOSAL 3:
AMENDMENT OF ARTICLE TENTH C OF THE AMENDED AND RESTATED
ARTICLES OF INCORPORATION
Proposal 3 is presented by the Board to amend
Article TENTH C of our Articles. Proposal 3 eliminates
director term limits and certain provisions that have been
addressed in Proposal 3.
TENTH:
C. The term each group member subsequently elected
at the Shareholders Annual Meeting will occupy will be three (3)
years. Every director will perform his/her duties until his/her
successor is duly elected and in possession of his/her position.
No director, except the Corporations President, while
fulfilling said hierarchic duties, may be elected for more than
three (3) terms or serve as such for more than nine (9)
years. The President of the Corporation, which
is also shall be a member of the Board
of Directors, and will be
is
32
excluded from the aforementioned groups. Every director
will perform
his/her
duties until
his/her
successor is duly elected and in possession of
his/her
position.
Reasons
for Voting in Favor of the Proposal
Our Board has considered the advantages and disadvantages of
current director term limits, and has voted to approve
Proposal 3 and recommends it to our shareholders as being
in the best interest of the Corporation and our shareholders.
The elimination of director term limits is inteded to provide
and promote greater stability, continuity and knowledge of the
Corporations business affairs and financial strategies.
The approval of Proposal 3 would ensure the retention of
directors with prior experience as directors of the Corporation
and that are familiar with the Corporations strategies and
operations. Experienced directors are a valuable resource and,
with their knowledge about the Corporations business and
affairs, are better positioned to make decisions that are in the
best interests of the Corporation and its shareholders. The
Board believes that maintaining director term limits would risk
the loss of directors with core knowledge of the Corporation,
its business and its operations that has been gained during
their service to the Corporation and its shareholders. The Board
believes that the elimination of director term limits will also
help attract more qualified candidates who are willing to commit
the time and dedication necessary to understand the Corporation
and its competitive environment.
Moreover, the elimination of director term limits does not
compromise the directors accountability to our
shareholders. Every director is required to uphold his or her
fiduciary duties to the Corporation and our shareholders,
regardless of whether the duration of the directors stay
on the Board. Although the shareholders have an opportunity to
express any dissatisfaction they may have with a director by
withholding votes from said director when standing for election,
if this proposal is approved, our current and any future
director may be indefinitely elected to our Board.
Vote
Requirement
The affirmative vote of the majority of the issued and
outstanding shares of common stock entitled to vote on the
record date is required to approve the amendment to
Article TENTH C of the Articles.
The Board believes that the proposal to approve the amendment
to Article TENTH C of the Articles is in the best interests
of our shareholders and recommends a vote FOR the proposal.
PROPOSAL 4:
APPROVAL OF THE TRIPLE-S MANAGEMENT CORPORATION 2007 INCENTIVE
PLAN
2007
Incentive Plan
On October 16, 2007, our Board adopted the Triple-S
Management Corporation 2007 Incentive Plan (the
Plan). The purposes of our Plan are to create
incentives designed to motivate our employees to significantly
contribute toward our growth and profitability, to provide our
executives, directors and other employees, and persons who, by
their position, ability and diligence, are able to make
important contributions to our growth and profitability, with an
incentive to assist us in achieving our long-term corporate
objectives, to attract and retain executives and other employees
of outstanding competence, and to provide such persons with an
opportunity to acquire an equity interest in us.
According to the Plan, we may grant incentive stock options,
non-qualified stock options, stock appreciation rights,
restricted stock, deferred shares, performance awards, including
cash bonus awards, and other stock-based awards, to our officers
and key employees, and those of our subsidiaries. In addition,
the Plan authorized the grant of equity-based compensation
incentives to our directors and to any independent contractors
and consultants who by their position, ability and diligence are
able to make important contributions to our future growth and
profitability. Generally, all classes of our employees are
eligible to participate in the Plan. On October 16, 2007
the Board awarded performance stocks, restricted stocks and
stock options to various executive officers of the Corporation.
33
We have reserved a maximum of 4,700,000 shares of our
authorized Class B common stock for issuance upon the
exercise of awards to be granted pursuant to the Plan. Each
share issued under an option or under a restricted stock award
will be counted against this limit. Shares to be delivered at
the time a stock option is exercised or at the time a restricted
stock award is made may be available from authorized but
unissued shares or from stock previously issued but which we
have reacquired and hold in our treasury.
Shareholder approval will provide shareholders with a complete
picture of all aspects of director and executive compensation,
and to qualify the Plan with the Department of the Treasury of
the Commonwealth of Puerto Rico, which would allow the recipient
of a grant of qualified stock options to receive certain tax
benefits. The following is a summary of the material provisions
of the Plan and is qualified in its entirety by reference to the
complete text of the Plan, a copy of which is attached to this
proxy statement as Exhibit B.
Plan Term. The Plan will have a
10-year
term, subject to earlier termination by our Board.
Authorized Shares. Subject to adjustment, up
to 4,700,000 of the shares of our Class B shares
outstanding after this offering will be available for awards to
be granted under the Plan. No participant in the Plan may
receive stock options and stock appreciation rights in any
calendar year that relate to more than 600,000 shares of
our class B shares. Shares of common stock to be issued
under the Plan may be made available from authorized but
unissued Class B shares or Class B shares that we
acquire.
If an award (other than a substitute award as defined below)
terminates, is forfeited, cancelled or settled for cash then the
shares covered by such award will again be available for
issuance under the Plan. In addition, shares tendered or
withheld in payment of an exercise price or for withholding
taxes also will again be available for issuance under the Plan.
Shares of our common stock underlying substitute awards shall
not reduce the number of such shares available for delivery
under the Plan. A substitute award is any award
granted in assumption of, or in substitution for, an outstanding
award previously granted by a company acquired by us or with
which we combine.
Administration. The Compensation Committee
will administer the Plan and will have authority to select
individuals to whom awards are granted, determine the types of
awards and number of shares covered, and determine the terms and
conditions of awards, including the applicable vesting schedule,
performance conditions, and whether the award will be settled in
cash, shares or a combination of the two.
Types of Awards. The Plan will provide for
grants of incentive stock options, non-qualified stock options,
stock appreciation rights, restricted stock, deferred shares,
performance awards, including cash bonus awards, and other
stock-based awards.
|
|
|
|
|
Stock options. An option is the right to
purchase shares of Class B common stock at a future date at
a specified exercise price. The per share exercise price of
options will be determined by the Compensation Committee but may
not be less than the closing price of a share of our
Class B common stock on the date of grant (other than a
substitute award). The Compensation Committee determines the
date after which options may be exercised in whole or in part,
and the expiration date of each option. However, no option award
will be exercisable after the expiration of 10 years from
the date the option is granted.
|
|
|
|
Stock appreciation rights. A stock
appreciation right is a contractual right granted to the
participant to receive, in cash or shares, an amount equal to
the appreciation of one share of Class B common stock from
the date of grant. Any stock appreciation rights will be granted
subject to the same terms and conditions applicable to options,
as described above.
|
|
|
|
Restricted stock/restricted stock
units. Shares of restricted stock are shares of
our Class B common stock subject to restrictions on
transfer and a substantial risk of forfeiture. A restricted
stock unit consists of a contractual right denominated in shares
of our Class B common stock which represents the right to
receive the value of a share of Class B common stock at a
future date, subject to certain vesting and other restrictions.
While we currently intend that these awards generally will
provide at least a
3-year
vesting period if vesting is based on continued employment
(1 year if based on achievement of performance objectives),
restricted stock and restricted stock units will be subject to
|
34
|
|
|
|
|
restrictions and such other terms and conditions as the
Compensation Committee may determine, which restrictions and
such other terms and conditions may lapse separately or in
combination at such time or times, in such installments or
otherwise, as the Compensation Committee may deem appropriate.
|
|
|
|
|
|
Performance Awards. The Plan will provide that
grants of performance awards, including cash-denominated awards
and (if determined by the Compensation Committee) restricted
stock, restricted stock units or other stock-based awards, will
be made based upon, and subject to achieving, certain
performance objectives. Performance objectives with
respect to those awards that are intended to qualify as
performance-based compensation for purposes of
Section 162(m) of the Internal Revenue Code are limited to
premiums earned; net sales; revenue; revenue growth or product
revenue growth; operating income (before or after taxes); pre-
or after-tax income (before or after allocation of corporate
overhead and bonus); net earnings; earnings per share; net
income (before or after taxes); return on equity; total
shareholder return; return on assets or net assets; appreciation
in and/or
maintenance of share price; market share; gross profits;
earnings (including earnings before taxes, earnings before
interest and taxes or earnings before interest, taxes,
depreciation and amortization); economic value-added models or
equivalent metrics; comparisons with various stock market
indices; reductions in costs; cash flow or cash flow per share
(before or after dividends); return on capital (including return
on total capital or return on invested capital); cash flow
return on investment; improvement in or attainment of expense
levels or working capital levels; operating margins, gross
margins, net margin or cash margin; year-end cash; debt
reductions; shareholder equity; market share; regulatory
achievements; and implementation, completion or attainment of
measurable objectives with respect to research, development,
products or projects and recruiting and maintaining personnel.
The maximum number of shares of our Class B common stock
subject to a performance award in any fiscal year is
150,000 shares and the maximum amount that can be earned in
respect of a performance award denominated in cash or value
other than shares on an annualized basis is $3.0 million
|
|
|
|
Deferred shares. An award of deferred shares
entitles the participant to receive shares of our Class B
common stock upon the expiration of a specified deferral period.
In addition, deferred shares may be subject to restrictions on
transferability, forfeiture and other restrictions as determined
by the Compensation Committee.
|
|
|
|
Other awards. The Compensation Committee is
authorized to grant other stock-based awards, either alone or in
addition to other awards granted under the Plan. Other awards
may be settled in shares, cash, awards granted under the Plan or
any other form of property as the Compensation Committee
determines.
|
Eligibility. All our employees and members of
our Board will be eligible to participate in the Plan. From time
to time, our Board will determine who will be granted awards,
the number of shares or performance units subject to such
grants, and the terms of awards. Under the Plan, awards may be
granted to our employees, our directors and other individuals
providing services to us, including but not limited to
consultants, advisors and independent contractors. As of
December 31, 2007, there were about 2,300 people who
would have been eligible to receive awards under the Plan.
Adjustments. The Compensation Committee shall
adjust the terms of any outstanding awards and the number of
shares of Class B common stock issuable under the Plan for
any change in shares of our common stock resulting from a stock
split, reverse stock split, stock dividend, spin-off,
combination or reclassification of our Class B common
stock, an issuance of shares pursuant to the anti-dilution
provisions of the Class B common stock or any other event
that affects our capitalization if the Compensation Committee
determines an adjustment is equitable or appropriate.
Termination of Service and Change in
Control. The Compensation Committee will
determine the effect of a termination of employment and a change
in control (as defined in the Plan) or service on awards granted
under the Plan.
Plan Benefits. Future benefits under the Plan
are not currently determinable. However, current benefits
granted to our directors, named executive officers and all our
other employees would not have been increased
35
if they had been made under the Plan. Grants of performance
stock, restricted stock and stock options to our named executive
officers are shown in the Grant of Plan-Based Awards table in
the proxy statement.
Amendment, Modification and Termination. The
Board may from time to time suspend, discontinue, revise or
amend the Plan and the Compensation Committee may amend the
terms of any award in any respect, provided that no such action
will adversely impair or affect the rights of a holder of an
outstanding award under the Plan without the holders
consent, and no such action will be taken without shareholder
approval, if required by the rules of the stock exchange on
which our shares are traded.
Vote
Requirement
The affirmative vote of the majority of the votes present in
person or by proxy by shareholders entitled to vote at the
Annual Meeting of Shareholders is required to approve the Plan.
Therefore, abstentions shall have the effect of a vote against
the proposal. Broker-non-votes will have no effect on the
proposal.
The Board believes that the proposal to approve the Plan is
in the best interests of our shareholders and recommends a vote
FOR the proposal.
* * *
APPOINTMENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee intends to retain the services of KPMG LLP,
as independent registered public accounting firm, to audit the
consolidated financial statements of the Corporation for the
fiscal year ending December 31, 2008. Representatives of
KPMG LLP will be present at the annual meeting and will be given
an opportunity to make a statement if so desired and to respond
to appropriate questions.
DISCLOSURE
OF AUDITORS FEES
The following is a description of the fees paid or accrued by us
for the professional services rendered by KPMG LLP for the years
ended December 31, 2007 and 2006:
Audit
Fees
The aggregate fees paid or accrued by us for professional
services rendered by KPMG LLP for the audit of our annual
financial statements as of and for the years ended
December 31, 2007 and 2006, and for the reviews of the
financial statements included in our quarterly reports on
Form 10-Q
were $1,045,000 and $908,000, respectively.
Audit-Related
Fees
The aggregate fees paid or accrued by us for professional
services rendered by KPMG LLP as of and for the years ended
December 31, 2007 and 2006 were $234,000 and $30,000,
respectively. The 2007 fees were related to work performed in
the IPO registration statements such as due diligence and
issuance of the comfort letter. The 2006 fees were associated
with due diligence services related to the acquisition of Great
American Life Assurance Company (Triple-S Vida, Inc.).
Tax
Fees
The aggregate fees paid or accrued by us for professional
services rendered by KPMG LLP for tax compliance, tax advice and
tax consulting as of and for the year ended December 31,
2006 was $11,000. For the year ended December 31, 2007,
there were no fees paid or accrued.
All Other
Fees
The aggregate fees paid or accrued by us for professional
services rendered by KPMG LLP other than those previously
reported as of and for the year ended December 31, 2007 was
$23,000. The 2007 fees were
36
associated with the work performed to issue the Statement of
Actuarial Opinion included in the Seguros Triple-S, Inc.
statutory filing. For the year ended December 31, 2006,
there were no fees paid or accrued.
Pre-Approval
Policies and Procedures
All auditing services and non-audit services must be
pre-approved by the Audit Committee. Pre-approval is not
required for non-audit services if: (1) the aggregate
dollar value of such services does not exceed five percent of
the total fees paid by the Corporation to the external auditors
during the fiscal year in which the non-audit services are
provided, (2) such services were not recognized by the
Corporation at the time of the engagement to be non-audit
services, and (3) such services are promptly brought to the
attention of and approved by the Audit Committee prior to the
completion of the audit.
All non-audit services were pre-approved by the Audit Committee.
v v v
PROPOSALS OF
SECURITY HOLDERS TO BE PRESENTED AT THE 2009 ANNUAL MEETING OF
SHAREHOLDERS
To be eligible for inclusion in the proxy statement and proxy
card for our 2009 annual meeting of shareholders,
shareholders proposals must be received by the
boards Secretary, at its principal executive offices, 1441
F.D. Roosevelt Avenue, 6th Floor, San Juan, Puerto
Rico, 00920, no later than November 27, 2008.
If the proposal meets the applicable legal and statutory
requirements, it will be included in the Proxy Statement and
proxy card for our 2009 annual meeting of shareholders. Our
Bylaws provide that a shareholder may present a proposal
(including a nomination for election to the Board) at the 2009
Annual Meeting and be voted upon by shareholders if it is made
by a shareholder who is a record holder as of the applicable
record date and such shareholder has delivered written notice of
such proposal (containing the information specified in our
Bylaws) to the boards Secretary, at its principal
executive offices, 1441 F.D. Roosevelt Avenue, 6th Floor,
San Juan, Puerto Rico, 00920, not earlier than
November 27, 2008 nor later than December 27, 2008.
San Juan,
Puerto Rico, March 27, 2008
|
|
|
|
|
|
WILMER RODRÍGUEZ-SILVA, MD
Chairman of the Board
|
|
LUIS A. CLAVELL-RODRÍGUEZ, MD
Secretary of the Board
|
YOU MAY REQUEST A COPY, FREE OF CHARGE, OF OUR REPORT ON
FORM 10-K
(WITHOUT EXHIBITS) FOR THE YEAR 2006 AS FILED WITH THE SEC OR BY
CALLING
(787) 749-4949
OR WRITING TO SANTIA BARTOLOMEI, MANAGER, TRIPLE-S MANAGEMENT
CORPORATION, PO BOX 363628, SAN JUAN, PR
00936-3628.
37
Exhibit A
Independence Standards of the Board of
Directors
The following individuals shall not be deemed an
independent director of the Company:
1. A director who is an employee or whose immediate family
member1
is an executive officer of the
Company2
would not be independent until three years after the end of such
employment relationship;
2. A director who receives or whose immediate family member
receives during any twelve-month period more than $100,000 in
direct
compensation3
from the Company, would not be independent until three years
after he or she ceases to receive more than $100,000 per year in
such compensation;
3. A director who is affiliated with or employed by, or
whose immediate family member is affiliated with or employed in
a professional capacity by, a present or former internal or
external auditor of the Company would not be independent until
three years after the end of the affiliation or the employment
or auditing relationship;
4. A director or an immediate family member who is
employed, as an executive officer of another company where any
of the Companys present executive officers serve on that
companys compensation committee would not be independent
until three years after the end of such service or the
employment relationship; or
5. A director who is an employee, or whose immediate family
member is an executive officer of a company that makes payments
to, or receives payments from, the Company for property or
services in an amount which, in any single fiscal year, exceeds
the greater of $1 million, or 2% of such other
companys consolidated gross revenues, would not be
independent until three years after falling below such threshold.
Moreover, no director qualifies as independent
unless the Board of Directors of Triple-S Management Corporation
affirmatively so determines that he or she has no material
relationship with the company.
Exhibit B
Triple-S Management Corporation 2007 Incentive
Plan
Section 1. Purpose. The
purpose of the Triple-S Management Corporation 2007 Incentive
Plan is to enhance the incentive of those employees, directors
and other individuals who are expected to contribute
significantly to the success of the Company and its Affiliates
to perform at the highest level, and, in general, to further the
best interests of the Company and its shareholders.
Section 2. Definition.
As used in the Plan, the following terms shall have the meanings
set forth below:
(a) Act shall mean the Securities
Exchange Act of 1934, as amended.
(b) Affiliate shall mean (i) any
entity that, directly or indirectly, is controlled by or under
common control with the Company and (ii) any entity in
which the Company has a significant equity interest, in either
case as determined by the Committee.
(c) Award shall mean any Option, Stock
Appreciation Right, Restricted Stock, Restricted Stock Unit,
Performance Award or Other Stock-Based Award granted under the
Plan, which may be denominated or settled in Shares, cash or in
such other forms as provided for herein.
1 Immediate
family member includes a persons spouse, parents,
children, siblings, mothers- and
fathers-in-law,
sons- and
daughters-in-law,
brothers- and
sisters-in-law,
and anyone (other than domestic employees) who shares such
persons home.
2 Company
includes any parent or subsidiary of Triple-S Management
Corporation.
3 Direct
compensation received from the Company does not include director
and committee fees, and pension or other forms of deferred
compensation for prior service no contingent on continued
service.
38
(d) Award Agreement shall mean any
agreement, contract or other instrument or document evidencing
any Award granted under the Plan, which may, but need not, be
executed or acknowledged by a Participant.
(e) Beneficiary shall mean a person or
persons entitled to receive payments or other benefits or
exercise rights that are available under the Plan in the event
of the Participants death. If no such person is named by a
Participant who is an individual, such individuals
Beneficiary shall be the individuals estate.
(f) Board shall mean the board of
directors of the Company.
(g) Change in Control shall mean the
occurrence of:
(i) any person (as defined in
Section 13(d) of the Act) other than the Company, its
Affiliates or an employee benefit plan or trust maintained by
the Company or its affiliates, becoming the beneficial
owner (as defined in
Rule 13d-3
under the Act), directly or indirectly, of more than 30% of the
combined voting power of the Companys then outstanding
securities (excluding any person who becomes such a
beneficial owner in connection with a transaction described in
clause (A) of paragraph (iii) below), unless such
person acquires beneficial ownership of more than 30% of the
combined voting power of the Companys Voting Stock then
outstanding solely as a result of an acquisition of Company
Voting Stock by the Company which, by reducing the Company
Voting Stock outstanding, increases the proportionate Company
Voting Stock beneficially owned by such person to more than 30%
of the combined voting power of the Companys Voting Stock
then outstanding; provided, that if a person shall become
the beneficial owner of more than 30% of the combined voting
power of the Companys Voting Stock then outstanding by
reason of such Voting Stock acquisition by the Company and shall
thereafter become the beneficial owner of any additional Company
Voting Stock which causes the proportionate voting power of such
Company Voting Stock beneficially owned by such person to
increase to more than 30% of the combined voting power of such
Voting Stock then outstanding, such person shall, upon becoming
the beneficial owner of such additional Company Voting Stock, be
deemed to have become the beneficial owner of more than 30% of
the combined voting power of the Companys Voting Stock
then outstanding other than solely as a result of such Voting
Stock acquisition by the Company;
(ii) at any time during a period of twelve consecutive
months, individuals who at the beginning of such period
constituted the Board and any new member of the Board whose
election by the Board or nomination for election by the
Companys shareholders was approved by a vote of at least a
majority of the directors then still in office who were
directors at the beginning of such twelve-month period or whose
election or nomination for election was so approved, cease for
any reason to constitute a majority of members then constituting
the Board; or
(iii) the consummation of (A) a merger or
consolidation of the Company or any direct or indirect
subsidiary of the Company with any other corporation, other than
a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior to such
merger or consolidation continuing to represent (either by
remaining outstanding or being converted into voting securities
of the surviving entity or any parent thereof) at least 50% of
the combined voting power or the total fair market value of the
securities of the Company or such surviving entity or any parent
thereof outstanding immediately after such merger or
consolidation, or (B) any sale, lease, exchange or other
transfer (in one transaction or a series of transactions) of all
or substantially all assets of the Company.
Notwithstanding the foregoing, in no event shall a Change in
Control be deemed to have occurred with respect to a Participant
if the Participant is part of a group, within the
meaning of Section 13(d)(3) of the Act, which consummates
the Change in Control transaction. In addition, for purposes of
the definition of
Change in Control, a person engaged in business as an
underwriter of securities shall not be deemed to be the
beneficial owner of, or to beneficially own, any securities
acquired through such
39
persons participation in good faith in a firm commitment
underwriting until the expiration of forty days after the date
of such acquisition.
(h) Code shall mean the Internal Revenue
Code of 1986, as amended from time to time.
(i) Committee shall mean the
Compensation Committee of the Board or such other committee as
may be designated by the Board. If the Board does not designate
the Committee, references herein to the Committee
shall refer to the Board.
(j) Company shall mean Triple-S
Management Corporation.
(k) Covered Employee means an individual
who is (i) a covered employee within the
meaning of Section 162(m)(3) of the Code, or any successor
provision thereto or (ii) expected by the Committee to be
the recipient of compensation (other than qualified
performance based compensation as defined in
Section 162(m) of the Code) in excess of $1,000,000 for the
tax year of the Company with regard to which a deduction in
respect of such individuals Award would be claimed.
(l) Fair Market Value shall mean with
respect to Shares, the closing price of a Share on the date in
question (or, if there is no reported sale on such date, on the
last preceding date on which any reported sale occurred) on the
principal stock exchange on which the Shares trade or are
quoted, or if Shares are not so listed or quoted, fair market
value as determined by the Committee, and with respect to any
property other than Shares, the fair market value of such
property determined by such methods or procedures as shall be
established from time to time by the Committee.
(m) Incentive Stock Option shall mean an
option representing the right to purchase Shares from the
Company, granted under and in accordance with the terms of
Section 6, that meets the requirements of Section 422
of the Code, or any successor provision thereto.
(n) Non-Qualified Stock Option shall
mean an option representing the right to purchase Shares from
the Company, granted under and in accordance with the terms of
Section 6, that is not an Incentive Stock Option or a
Qualified Stock Option.
(o) Option shall mean an Incentive Stock
Option, a Qualified Stock Option or a Non-Qualified Stock Option.
(p) Other Stock-Based Award means an
Award granted pursuant to Section 9 of the Plan.
(q) Participant shall mean the recipient
of an Award granted under the Plan.
(r) Performance Award means an Award
granted pursuant to Section 8 of the Plan.
(s) Performance Period means the period
established by the Committee at the time any Performance Award
is granted or at any time thereafter during which any
performance goals specified by the Committee with respect to
such Award are measured.
(t) Plan shall mean the Triple-S
Management Corporation 2007 Incentive Plan, as the same may be
amended from time to time.
(u) PR Code means the Puerto Rico
Internal Revenue Code of 1994, as amended, any successor thereto
and any regulation promulgated thereunder.
(v) Qualified Stock Option means an
option that meets the requirement of Section 1046 of the PR
Code.
(w) Restricted Stock shall mean any
Share granted under Section 8.
(x) Restricted Stock Unit shall mean a
contractual right granted under Section 8 that is denominated in
Shares. Each Unit represents a right to receive the value of one
Share (or a percentage of such value) upon the terms and
conditions set forth in the Plan and the applicable Award
Agreement. Awards of Restricted Stock Units may include, without
limitation, the right to receive dividend equivalents.
40
(y) SAR or Stock Appreciation
Right shall mean any right granted to a Participant
pursuant to Section 7 to receive, upon exercise by the
Participant, the excess of (i) the Fair Market Value of one
Share on the date of exercise or at any time during a specified
period before the he date of exercise over (ii) the grant
price of the right on the date of grant, or if granted in
connection with an outstanding Option on the date of grant of
the related Option, as specified by the Committee in its sole
discretion, which, except in the case of Substitute Awards or in
connection with an adjustment provided in Section 5(d),
shall not be less than the Fair Market Value of one Share on
such date of grant of the right or the related Option, as the
case may be.
(z) Shares shall mean shares of the
Class B common stock of the Company.
(aa) Subsidiary shall mean any
corporation of which stock representing at least 50% of the
ordinary voting power is owned, directly or indirectly, by the
Company.
(bb) Substitute Awards shall mean Awards
granted in assumption of, or in substitution for, outstanding
awards previously granted by a company acquired by the Company
or with which the Company combines.
(cc) Termination of Employment means, in
the case of a Participant who is an employee of the Company or
any of its Affiliates, cessation of the employment relationship
such that the Participant is no longer an employee of the
company or an Affiliate, or, in the case of a Participant who is
an independent contractor, the date the performance of services
for the Company or an Affiliate has ended; provided,
however, that in the case of an employee, the transfer
of employment from the Company to an Affiliate, from an
Affiliate to the Company, from one Affiliate to another
Affiliate or, unless the Committee determines otherwise, the
cessation of employee status but the continuation of the
performance of services for the Company or an Affiliate as an
independent contractor shall not be deemed a termination of
service that would constitute a Termination of Employment; and
provided, further, that a Termination of
Employment will be deemed to occur for a Participant employed by
an Affiliate when an Affiliate ceases to be an Affiliate unless
such Participants employment continues with the Company or
another Affiliate.
(dd) Voting Stock means securities
entitled to vote generally in the election of members of the
board of directors.
Section 3. Eligibility.
(a) Any employee, director, consultant or other advisor of,
or any other individual who provides services to, the Company or
any Affiliate, shall be eligible to be selected to receive an
Award under the Plan.
(b) Holders of options and other types of Awards granted by
a company acquired by the Company or with which the Company
combines are eligible for grant of Substitute Awards hereunder.
Section 4. Administration.
(a) The Plan shall be administered by the Committee. The
Committee shall be appointed by the Board and shall consist of
not less than three directors. Each Committee member shall be
(i) independent, within the meaning of and to the extent
required by applicable rulings and interpretations of the
applicable stock exchange on which the Shares trade or are
quoted, (ii) a non-employee director within the meaning of
Rule 16b-3
under the Act and (iii) an outside director pursuant to
Section 162(m) of the Code, and any regulations issued
thereunder, in each case at such time as the Company becomes
subject to the respective regulatory regime. The Board may
designate one or more directors as alternate members of the
Committee who may replace any absent or disqualified member at
any meeting of the Committee. To the extent permitted by
applicable law, the Committee may delegate to one or more
officers of the Company the authority to grant Awards except
that such delegation shall not be applicable to any Award for a
person then covered by Section 16 of the Act. The Committee
may issue rules and regulations for administration of the Plan.
It shall meet at such times and places as it may determine.
(b) Subject to the terms of the Plan and applicable law,
the Committee (or its delegate) shall have full power and
authority to: (i) designate Participants;
(ii) determine the type or types of Awards (including
41
Substitute Awards) to be granted to each Participant under the
Plan; (iii) determine the number of Shares to be covered by
(or with respect to which payments, rights, or other matters are
to be calculated in connection with) Awards; (iv) determine
the terms and conditions of any Award; (v) determine
whether, to what extent, and under what circumstances Awards may
be settled or exercised in cash, Shares, other securities, or
other Awards, or canceled, forfeited or suspended, and the
method or methods by which Awards may be settled, exercised,
canceled, forfeited or suspended; (vi) determine whether,
to what extent, and under what circumstances cash, Shares, other
securities, other Awards, and other amounts payable with respect
to an Award under the Plan shall be deferred either
automatically or at the election of the holder thereof or of the
Committee; (vii) interpret and administer the Plan and any
instrument or agreement relating to, or Award made under, the
Plan; (viii) establish, amend, suspend or waive such rules
and regulations and appoint such agents as it shall deem
appropriate for the proper administration of the Plan; and
(ix) make any other determination and take any other action
that the Committee deems necessary or desirable for the
administration of the Plan.
(c) All decisions of the Committee shall be ratified by the
Board of Directors and be final, conclusive and binding upon all
parties, including the Company, the shareholders and the
Participants.
Section 5. Shares Available
for Awards and Award Limitation.
(a) Subject to adjustment as provided below, the maximum
number of Shares available for issuance under the Plan will not
exceed 4,700,000 Shares. Notwithstanding the foregoing and
subject to adjustment as provided in Section 5(d), no
Participant may receive under the Plan in any calendar year
(i) Options or Stock Appreciation Rights that relate to
more than 600,000 Shares; (ii) Restricted Stock and
RSUs that relate to more than 150,000 Shares; or
(iii) Performance Awards or Other Stock-Based Awards that
relate to more than 150,000 Shares; and the maximum amount
that may be paid in a calendar year in respect of an annual
Award denominated in cash or value other than Shares with
respect to any Participant shall be $3,000,000, and the maximum
amount of a long-term incentive Award denominated in a cash
shall be $1,500,000 multiplied by the number of years included
in any applicable Performance Period(s) (and any applicable
fraction for any Performance Period(s) of less than one year)
relating to such Awards.
(b) Any shares subject to an Award (but not including any
Substitute Award), that expires, is cancelled, forfeited, or
otherwise terminates without the delivery of Shares, including
(i) the number of Shares surrendered or withheld in payment
of any exercise or price of an Award or taxes related to an
Award and (ii) any Shares subject to an Award to the extent
that Award is settled without the issuance of Shares, shall
again be, or shall become, available for distribution under the
Plan.
(c) Any Shares delivered pursuant to an Award may consist,
in whole or in part, of authorized and unissued Shares or Shares
acquired by the Company.
(d) In the event that the Committee shall determine that
any dividend or other distribution (whether in the form of cash,
Shares or other securities), recapitalization, stock split,
reverse stock split, reorganization, merger, consolidation,
split-up,
spin-off, combination, repurchase or exchange of Shares or other
securities of the Company, issuance of warrants or other rights
to purchase Shares or other securities of the Company, issuance
of Shares pursuant to the anti-dilution provisions of the
Shares, or other similar corporate transaction or event affects
the Shares such that an adjustment is appropriate in order to
prevent dilution or enlargement of the benefits or potential
benefits intended to be made available under the Plan, then the
Committee shall adjust equitably any or all of (i) the
number and type of Shares (or other securities) which thereafter
may be made the subject of Awards, including the aggregate and
individual limits specified in Section 5(a), (ii) the
number and type of Shares (or other securities) subject to
outstanding Awards, and (iii) the grant, purchase, or
exercise price with respect to any Award or, if deemed
appropriate, make provision for a cash payment to the holder of
an outstanding Award; provided, however, that the number
of Shares subject to any Award denominated in Shares shall
always be a whole number.
(e) Shares underlying Substitute Awards shall not reduce
the number of Shares remaining available for issuance under the
Plan.
42
Section 6. Options.
The Committee is hereby authorized to grant Options to
Participants with the following terms and conditions and with
such additional terms and conditions, in either case not
inconsistent with the provisions of the Plan, as the Committee
shall determine:
(a) The purchase price per Share under an Option shall be
determined by the Committee; provided, however,
that, except in the case of Substitute Awards, such purchase
price shall not be less than the Fair Market Value of a Share on
the date of grant of such Option.
(b) The term of each Option shall be fixed by the Committee
but shall not exceed 7 years from the date of grant thereof.
(c) The Committee shall determine the time or times at
which an Option may be exercised in whole or in part.
(d) The Committee shall determine the method or methods by
which, and the form or forms, including, without limitation,
cash, Shares, other Awards, or any combination thereof, having a
Fair Market Value on the exercise date equal to the relevant
exercise price, in which, payment of the exercise price with
respect thereto may be made or deemed to have been made.
(e) The terms of any Incentive Stock Option granted under
the Plan shall comply in all respects with the provisions of
Section 422 of the Code, or any successor provision
thereto, and any regulations promulgated thereunder.
(f) The terms of any Qualified Stock Option granted under
the Plan shall comply in all respects with the provisions of
Section 1046 of the PR Code, or any successor provision
thereto, and any regulations promulgated thereunder.
Section 7. Stock
Appreciation Rights.
(a) The Committee is hereby authorized to grant Stock
Appreciation Rights (SARs) to Participants
with terms and conditions as the Committee shall determine not
inconsistent with the provisions of the Plan.
(b) SARs may be granted hereunder to Participants either
alone (freestanding) or in addition to other
Awards granted under the Plan (tandem) and
may, but need not, relate to a specific Option granted under
Section 6.
(c) Any tandem SAR related to an Option may be granted at
the same time such Option is granted or at any time thereafter
before exercise or expiration of such Option. In the case of any
tandem SAR related to any Option, the SAR or applicable portion
thereof shall not be exercisable until the related Option or
applicable portion thereof is exercisable and shall terminate
and no longer be exercisable upon the termination or exercise of
the related Option, except that a SAR granted with respect to
less than the full number of Shares covered by a related Option
shall not be reduced until the exercise or termination of the
related Option exceeds the number of Shares not covered by the
SAR. Any Option related to any tandem SAR shall no longer be
exercisable to the extent the related SAR has been exercised.
(d) A freestanding SAR shall not have a term of greater
than 10 years or, unless it is a Substitute Award, an
exercise price less than 100% of Fair Market Value of the Share
on the date of grant.
Section 8. Restricted
Stock and Restricted Stock Units.
(a) The Committee is hereby authorized to grant Awards of
Restricted Stock and Restricted Stock Units to Participants.
(b) Shares of Restricted Stock and Restricted Stock Units
shall be subject to such restrictions as the Committee may
impose (including, without limitation, any limitation on the
right to vote a Share of Restricted Stock or the right to
receive any dividend or other right), which restrictions may
lapse separately or in combination at such time or times, in
such installments or otherwise, as the Committee may deem
appropriate.
43
(c) Any share of Restricted Stock granted under the Plan
may be evidenced in such manner as the Committee may deem
appropriate including, without limitation, book-entry
registration or issuance of a stock certificate or certificates.
In the event any stock certificate is issued in respect of
shares of Restricted Stock granted under the Plan, such
certificate shall be registered in the name of the Participant
and shall bear an appropriate legend referring to the terms,
conditions, and restrictions applicable to such Restricted Stock.
(d) The Committee may in its discretion, when it finds that
a waiver would be in the best interests of the Company, waive in
whole or in part any or all restrictions with respect to Shares
of Restricted Stock or Restricted Stock Units.
(e) If the Committee intends that an Award under this
Section 8 shall constitute or give rise to qualified
performance based compensation under Section 162(m)
of the Code, such Award may be structured in accordance with the
requirements of Section 9(c), including without limitation, the
performance criteria and the Award limitation set forth therein,
and any such Award shall be considered a Performance Award for
purposes of the Plan.
Section 9. Performance
Awards.
(a) The Committee is hereby authorized to grant Performance
Awards to Participants with terms and conditions as the
Committee shall determine not inconsistent with the provisions
of the Plan.
(b) Performance Awards may be denominated as a cash amount,
number of Shares, or a combination thereof and are Awards which
may be earned upon achievement or satisfaction of performance
conditions specified by the Committee. In addition, the
Committee may specify that any other Award shall constitute a
Performance Award by conditioning the right of a Participant to
exercise the Award or have it settled, and the timing thereof,
upon achievement or satisfaction of such performance conditions
as may be specified by the Committee. The Committee may use such
business criteria and other measures of performance as it may
deem appropriate in establishing any performance conditions.
Subject to the terms of the Plan, the performance goals to be
achieved during any Performance Period, the length of any
Performance Period, the amount of any Performance Award granted
and the amount of any payment or transfer to be made pursuant to
any Performance Award shall be determined by the Committee.
(c) Every Performance Award shall, if the Committee intends
that such Award should constitute qualified
performance-based compensation for purposes of Section
162(m) of the Code, include a pre-established formula, such that
payment, retention or vesting of the Award is subject to the
achievement during a performance period or periods, as
determined by the Committee, of a level or levels of, or
increases in, in each case as determined by the Committee, one
or more performance measures with respect to the Company,
including without limitation the following: revenue growth,
operating income growth, premiums earned; net sales;
revenue or product revenue growth; operating income (before
or after taxes); pre- or after-tax income (before or after
allocation of corporate overhead and bonus); net earnings;
earnings per share, earnings per share growth; net income
(before or after taxes); return on equity; total shareholder
return; return on assets or net assets; appreciation in
and/or
maintenance of share price; market share; gross profits;
earnings (including earnings before taxes, earnings before
interest and taxes or earnings before interest, taxes,
depreciation and amortization); comparisons with various stock
market indices; reductions in costs; cash flow or cash flow per
share (before or after dividends); return on capital (including
return on total capital or return on invested capital); cash
flow return on investment; improvement in or attainment of
expense levels or working capital levels; operating margins,
gross margins or cash margin; year-end cash; debt reductions;
shareholder equity; regulatory achievements; and implementation,
completion or attainment of measurable objectives with respect
to research, development, products or projects and recruiting
and maintaining personnel, each as determined in accordance with
generally accepted accounting principles, where applicable, as
consistently applied by the Company. Performance criteria may be
measured on an absolute (e.g., plan or budget) or
relative basis. Relative performance may be measured against a
group of peer companies, a financial market index, or other
acceptable objective and quantifiable indices. Except in the
case of an award intended to qualify as performance-based
compensation under Section 162(m) of the Code, if the
Committee determines that a change in the business, operations,
corporate structure or capital structure of the Company, or the
manner in which the Company conducts its business, or other
events or circumstances render the performance objectives
44
unsuitable, the Committee may modify the performance objectives
or the related minimum acceptable level of achievement, in whole
or in part, as the Committee deems appropriate and equitable.
Performance measures may vary from Performance Award to
Performance Award, respectively, and from Participant to
Participant, and may be established on a stand-alone basis, in
tandem or in the alternative. The Committee shall have the power
to impose such other restrictions on Awards subject to this
Section 9(c) as it may deem necessary or appropriate to
ensure that such Awards satisfy all requirements for
performance-based compensation within the meaning of
Section 162(m)(4)(C) of the Code, or any successor
provision thereto. Notwithstanding any provision of the Plan to
the contrary, the Committee shall not be authorized to increase
the amount payable under any Award to which this
Section 9(c) applies upon attainment of such
pre-established formula.
(d) Settlement of Performance Awards; Other Terms.
Settlement of Performance Awards shall be in cash, Shares, other
Awards or other property, or a combination thereof, in the
discretion of the Committee. Performance Awards will be
distributed only after the end of the relevant Performance
Period. The Committee may, in its discretion, increase or reduce
the amount of a settlement otherwise to be made in connection
with such Performance Awards, but may not exercise discretion to
increase any such amount payable to a Covered Employee in
respect of a Performance Award intended to qualify as
performance-based compensation for purposes of
Section 162(m) of the Code. Any settlement which changes
the form of payment from that originally specified shall be
implemented in a manner such that the Performance Award and
other related Awards do not, solely for that reason, fail to
qualify as performance-based compensation for
purposes of Section 162(m) of the Code. The Committee shall
specify the circumstances in which such Performance Awards shall
be paid or forfeited in the event of termination of employment
by the Participant.
Section 10. Other
Stock-Based Awards. The Committee is authorized,
subject to limitations under applicable law, to grant to
Participants such other Awards that may be denominated or
payable in, valued in whole or in part by reference to, or
otherwise based on, or related to, Shares or factors that may
influence the value of Shares, including, without limitation,
convertible or exchangeable debt securities, other rights
convertible or exchangeable into Shares, purchase rights for
Shares, Awards with value and payment contingent upon
performance of the Company or business units thereof or any
other factors designated by the Committee. The Committee shall
determine the terms and conditions of such Awards. Shares
delivered pursuant to an Award in the nature of a purchase right
granted under this Section 10 shall be purchased for such
consideration, paid for at such times, by such methods, and in
such forms, including, without limitation, cash, Shares, other
Awards, notes, or other property, as the Committee shall
determine. Cash awards, as an element of or supplement to any
other Award under the Plan, may also be granted pursuant to this
Section 10.
Section 11. Effect
of Termination of Service on Awards. The
Committee may provide, by rule or regulation or in any Award
Agreement, or may determine in any individual case, the
circumstances in which Awards shall be exercised, vested, paid
or forfeited in the event a Participant ceases to provide
Service to the Company or any Affiliate prior to the end of a
performance period or exercise or settlement of such Award.
Section 12. General
Provisions Applicable to Awards.
(a) Awards shall be granted for no cash consideration or
for such minimal cash consideration as may be required by
applicable law.
(b) Awards may, in the discretion of the Committee, be
granted either alone or in addition to or in tandem with any
other Award or any award granted under any other plan of the
Company. Awards granted in addition to or in tandem with other
Awards, or in addition to or in tandem with awards granted under
any other plan of the Company, may be granted either at the same
time as or at a different time from the grant of such other
Awards or awards.
(c) Subject to the terms of the Plan, payments or transfers
to be made by the Company upon the grant, exercise or payment of
an Award may be made in the form of cash, Shares, other
securities or other Awards, or any combination thereof, as
determined by the Committee in its discretion at the time of
grant, and may be made in a single payment or transfer, in
installments, or on a deferred basis, in each case in accordance
with rules and procedures established by the Committee. Such
rules and procedures may include, without limitation,
45
provisions for the payment or crediting of reasonable interest
on installment or deferred payments or the grant or crediting of
dividend equivalents in respect of installment or deferred
payments.
(d) Except as may be permitted by the Committee or as
specifically provided in an Award Agreement, (i) no Award
and no right under any Award shall be assignable, alienable,
saleable or transferable by a Participant otherwise than by will
or pursuant to Section 12(e) and (ii) each Award, and
each right under any Award, shall be exercisable during the
Participants lifetime only by the Participant or, if
permissible under applicable law, by the Participants
guardian or legal representative. The provisions of this
paragraph shall not apply to any Award which has been fully
exercised, earned or paid, as the case may be, and shall not
preclude forfeiture of an Award in accordance with the terms
thereof.
(e) A Participant may designate a Beneficiary or change a
previous beneficiary designation at such times prescribed by the
Committee by using forms and following procedures approved or
accepted by the Committee for that purpose. If no Beneficiary
designated by the Participant is eligible to receive payments or
other benefits or exercise rights that are available under the
Plan at the Participants death, the Beneficiary shall be
the Participants estate.
(f) All certificates for Shares
and/or
Shares or other securities delivered under the Plan pursuant to
any Award or the exercise thereof shall be subject to such stop
transfer orders and other restrictions as the Committee may deem
advisable under the Plan or the rules, regulations, and
other requirements of the Securities and Exchange Commission,
any stock exchange upon which such Shares or other securities
are then listed, and any applicable Federal or state securities
laws, and the Committee may cause a legend or legends to be put
on any such certificates to make appropriate reference to such
restrictions.
(g) Unless otherwise specifically provided in the
applicable Award Agreement, upon a Change in Control, the
Committee shall determine whether outstanding Options shall
become fully exercisable
and/or
vested and whether outstanding Awards (other than Options) shall
become fully vested
and/or
payable. In addition, the Committee shall determine the
treatment of outstanding Awards in connection with any
transaction or transactions resulting in a Change in Control.
(h) The Committee may impose restrictions on any Award with
respect to non-competition, confidentiality and other
restrictive covenants, as it deems necessary in its sole
discretion.
Section 13. Amendments
and Termination.
(a) Except to the extent prohibited by applicable law and
unless otherwise expressly provided in an Award Agreement or in
the Plan, the Board may amend, alter, suspend, discontinue, or
terminate the Plan or any portion thereof at any time;
provided, however, that no such amendment, alteration,
suspension, Discontinuation or termination shall be made without
(i) shareholder approval if such approval is required by
the listed company rules of the stock exchange, if any, on which
the Shares are principally traded or quoted or (ii) the
consent of the affected Participant, if such action would
adversely affect the rights of such Participant under any
outstanding Award, except to the extent any such amendment,
alteration, suspension, discontinuance or termination is made to
cause the Plan to comply with applicable law, stock exchange
rules and regulations or accounting or tax rules and
regulations. Notwithstanding anything to the contrary herein,
the Committee may amend the Plan in such manner as may be
necessary to enable the Plan to achieve its stated purposes in
any jurisdiction in a tax-efficient manner and in compliance
with local rules and regulations.
(b) The Committee may waive any conditions or rights under,
amend any terms of, or amend, alter, suspend, discontinue or
terminate, any Award theretofore granted, prospectively or
retroactively, without the consent of any relevant Participant
or holder or beneficiary of an Award, provided, however,
that no such action shall adversely affect the rights of any
affected Participant or holder or beneficiary under any Award
theretofore granted under the Plan, except to the extent any
such action is made to cause the Plan to comply with applicable
law, stock exchange rules and regulations or accounting or tax
rules and regulations; and provided further that, except
as provided in Section 5(d), no such action shall directly
or indirectly, through cancellation and regrant or any other
method, reduce, or have the effect of reducing, the exercise
price of any Award established at the time of grant thereof and
provided further, that the Committees authority
under this Section 13(b) is limited in the case of Awards
subject to Section 9(c), as set forth in Section 9(c).
46
(c) Except as noted in Section 9(c), the Committee
shall be authorized to make adjustments in the terms and
conditions of, and the criteria included in, Awards in
recognition of events (including, without limitation, the events
described in Section 5(d)) affecting the Company, or the
financial statements of the Company, or of changes in applicable
laws, regulations or accounting principles, whenever the
Committee determines that such adjustments are appropriate in
order to prevent dilution or enlargement of the benefits or
potential benefits intended to be made available under the Plan.
(d) Any provision of the Plan or any Award Agreement to the
contrary notwithstanding, the Committee may cause any Award
granted hereunder to be canceled in consideration of a cash
payment or alternative Award made to the holder of such canceled
Award equal in value to the Fair Market Value of such canceled
Award, except that this Section 13(d) shall not be
interpreted to permit any transaction that is prohibited by the
second proviso of Section 13(b) relating to the direct or
indirect repricing of Awards.
(e) The Committee may correct any defect, supply any
omission, or reconcile any inconsistency in the Plan or any
Award in the manner and to the extent it shall deem desirable to
carry the Plan into effect.
Section 14. Miscellaneous.
(a) No employee, Participant or other person shall have any
claim to be granted any Award under the Plan, and there is no
obligation for uniformity of treatment of employees,
Participants, or holders or beneficiaries of Awards under the
Plan. The terms and conditions of Awards need not be the same
with respect to each recipient. Any Award granted under the Plan
shall be a one-time Award which does not constitute a promise of
future grants. The Company, in its sole discretion, maintains
the Right to make available future grants hereunder.
(b) The Company shall be authorized to withhold from any
Award granted or any payment due or transfer made under any
Award or under the Plan or from any compensation or other amount
owing to a Participant the amount (in cash, Shares, other
securities or other Awards) of required withholding taxes due in
respect of an Award, its exercise, or any payment or transfer
under such Award or under the Plan and to take such other action
(including, without limitation, providing for elective payment
of such amounts in cash or Shares by the Participant) as may be
necessary in the opinion of the Company to satisfy all
obligations for the payment of such taxes.
(c) Nothing contained in the Plan shall prevent the Company
from adopting or continuing in effect other or additional
compensation arrangements, and such arrangements may be either
generally applicable or applicable only in specific cases.
(d) The grant of an Award shall not be construed as giving
a Participant the right to be retained in the employ of, or to
continue to provide services to, the Company or any Affiliate.
Further, the Company or the applicable Affiliate may at any time
dismiss a Participant, free from any liability, or any claim
under the Plan, unless otherwise expressly provided in the Plan
or in any Award Agreement or in any other agreement binding the
parties. The receipt of any Award under the Plan is not intended
to confer any rights on the receiving Participant except as set
forth in such Award.
(e) If any provision of the Plan or any Award is or becomes
or is deemed to be invalid, illegal, or unenforceable in any
jurisdiction, or as to any person or Award, or would disqualify
the Plan or any Award under any law deemed applicable by the
Committee, such provision shall be construed or deemed amended
to conform to applicable laws, or if it cannot be so construed
or deemed amended without, in the determination of the
Committee, materially altering the intent of the Plan or the
Award, such provision shall be stricken as to such jurisdiction,
person or Award, and the remainder of the Plan and any such
Award shall remain in full force and effect.
(f) Neither the Plan nor any Award shall create or be
construed to create a trust or separate fund of any kind or a
fiduciary relationship between the Company and a Participant or
any other person. To the extent that any person acquires a right
to receive payments from the Company pursuant to an Award, such
right shall be no greater than the right of any unsecured
general creditor of the Company.
47
(g) No fractional Shares shall be issued or delivered
pursuant to the Plan or any Award, and the Committee shall
determine whether cash or other securities shall be paid or
transferred in lieu of any fractional Shares, or whether such
fractional Shares or any rights thereto shall be canceled,
terminated or otherwise eliminated.
Section 15. Effective
Date of the Plan. The Plan shall be effective as
of November 1, 2007.
Section 16. Term
of the Plan. No Award shall be granted under the
Plan after the tenth year anniversary of its adoption by the
Board. However, unless otherwise expressly provided in the Plan
or in an applicable Award Agreement, any Award theretofore
granted may extend beyond such date, and the authority of the
Committee to amend, alter, adjust, suspend, discontinue, or
terminate any such Award, or to waive any conditions or rights
under any such Award, and the authority of the Board to amend
the Plan, shall extend beyond such date.
Section 17. Section 409A
of the Code. With respect to Awards subject to
Section 409A of the Code, the Plan is intended to comply
with the requirements of Section 409A, and the provisions
hereof shall be interpreted in a manner that satisfies the
requirements of Section 409A and the related regulations,
and the Plan shall be operated accordingly. If any provision of
the Plan or any term or condition of any Award would otherwise
frustrate or conflict with this intent, the provision, term or
condition will be interpreted and deemed amended so as to avoid
this conflict.
48
TRIPLE-S MANAGEMENT CORPORATION
P.O. Box 363628
San Juan, Puerto Rico 00936-3628
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Ramón M. Ruiz-Comas and Juan J. Román-Jiménez as proxies,
each with full power of substitution, to represent and vote as designated on the reverse side, all
the shares of each class of Common Stock of Triple-S Management Corporation held of record by the
undersigned on March 18, 2008, at the Annual Meeting of Shareholders to be held at the Ponce de
León Rooms A, B and C of the Condado Plaza Hotel, 999 Ashford Avenue, San Juan, Puerto Rico, or any
adjournment or postponement thereof.
Such
proxies may vote in their discretion upon such other business as may
properly be brought before the meeting or any adjournment
thereof.
(Continued and to be signed on the reverse side)
ANNUAL MEETING OF SHAREHOLDERS OF
TRIPLE-S MANAGEMENT CORPORATION
Sunday, April 27, 2008
PROXY VOTING INSTRUCTIONS
MAIL Date, sign and mail your proxy card in the envelope
provided as soon as possible.
- OR -
TELEPHONE Call toll-free 1-800-PROXIES
(1-800-776-9437) in the United States or 1-718-921-8500 from
foreign countries and follow the instructions. Have your
proxy card available when you call.
- OR -
INTERNET Access www.voteproxy.com and follow the
on-screen instructions. Have your proxy card available when
you access the web page.
- OR -
IN PERSON You may vote your shares in person by
attending the Annual Meeting.
|
|
|
|
|
|
|
COMPANY NUMBER
|
|
|
|
|
|
ACCOUNT NUMBER
|
|
|
|
|
|
|
|
|
|
|
|
You may enter your voting instructions at 1-800-PROXIES in the United States or 1-718-921-8500
from foreign countries or www.voteproxy.com up until Noon Eastern Time the day before the cut-off
or meeting date.
ê Please detach along perforated line and mail in the envelope provided IF you are not voting via telephone or the Internet. ê
THE
BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE ELECTION OF
DIRECTORS AND FOR PROPOSALS 2 THROUGH 4.
IF NO
DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED FOR ITEMS 1, 2, 3 AND
4.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE þ
|
|
|
|
|
|
|
1. Election of Three Group 1 Directors: |
|
|
|
|
|
|
|
|
|
|
|
NOMINEES: |
o
|
|
FOR ALL NOMINEES
|
|
O
O
|
|
José Hawayek-Alemañy, MD
Adamina Soto-Martínez, CPA |
o
|
|
WITHHOLD AUTHORITY
FOR ALL NOMINEES
|
|
O
|
|
Jorge L. Fuentes-Benejam, PE |
o
|
|
FOR ALL EXCEPT
(See instructions below) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INSTRUCTION: |
|
To withhold authority to vote for any individual nominee(s),
mark FOR ALL EXCEPT and fill in the circle next to each
nominee you wish to withhold, as shown here: l |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To change the address on your account, please check the box at right and
indicate your new address in the address space above. Please note that
changes to the registered name(s) on the account may not be submitted via
this method. |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN |
2.
|
|
Amendment of Article TENTH B of the Amended and Restated Articles of
Incorporation of Triple-S Management Corporation
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
3.
|
|
Amendment of Article TENTH C of the Amended and Restated Articles of
Incorporation of Triple-S Management Corporation
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
4.
|
|
Adoption of the Triple-S Management Corporation 2007 Incentive Plan
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature of Shareholder |
|
|
|
Date: |
|
|
|
Signature of Shareholder |
|
|
|
Date: |
|
|
|
|
|
Note: |
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly,
each holder should sign. When signing as executor, administrator, attorney, trustee or guardian,
please give full title as such. If the signer is a corporation, please sign full corporate name by
duly authorized officer, giving full title as such. If signer is a partnership, please sign in
partnership name by authorized person. |
ANNUAL MEETING OF SHAREHOLDERS OF
TRIPLE-S MANAGEMENT CORPORATION
Sunday, April 27, 2008
Please date, sign and mail
your proxy card in the
envelope provided as soon
as possible.
ê Please detach along perforated line and mail in the envelope provided. ê
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE ELECTION OF DIRECTORS AND FOR PROPOSALS 2 THROUGH 4.
IF NO DIRECTION IS GIVEN THIS PROXY WILL BE VOTED FOR ITEMS 1, 2, 3 AND 4.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE þ
|
|
|
|
|
|
|
1. Election of Three Group 1 Directors: |
|
|
|
|
|
|
|
|
|
|
|
NOMINEES: |
o
|
|
FOR ALL NOMINEES
|
|
O
O
|
|
José Hawayek-Alemañy, MD
Adamina Soto-Martínez, CPA |
o
|
|
WITHHOLD AUTHORITY
FOR ALL NOMINEES
|
|
O
|
|
Jorge L. Fuentes-Benejam, PE |
o
|
|
FOR ALL EXCEPT
(See instructions below) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INSTRUCTION: |
|
To withhold authority to vote for any individual nominee(s),
mark FOR ALL EXCEPT and fill in the circle next to each
nominee you wish to withhold, as shown here: l |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To change the address on your account, please check the box at right and
indicate your new address in the address space above. Please note that
changes to the registered name(s) on the account may not be submitted via
this method. |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN |
2.
|
|
Amendment of Article TENTH B of the Amended and Restated Articles of
Incorporation of Triple-S Management Corporation
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
3.
|
|
Amendment of Article TENTH C of the Amended and Restated Articles of
Incorporation of Triple-S Management Corporation
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
4.
|
|
Adoption of the Triple-S Management Corporation 2007 Incentive Plan
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature of Shareholder |
|
|
|
Date: |
|
|
|
Signature of Shareholder |
|
|
|
Date: |
|
|
|
|
|
Note: |
|
Please sign exactly as your name or names appear on this Proxy. When shares are held jointly,
each holder should sign. When signing as executor, administrator, attorney, trustee or guardian,
please give full title as such. If the signer is a corporation, please sign full corporate name by
duly authorized officer, giving full title as such. If signer is a partnership, please sign in
partnership name by authorized person. |